<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Frontiers in Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32174851</article-id>
<article-id pub-id-type="pmc">7054463</article-id>
<article-id pub-id-type="doi">10.3389/fpsyt.2020.00072</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kępińska</surname>
<given-names>Adrianna P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/909461" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iyegbe</surname>
<given-names>Conrad O.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/162044" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vernon</surname>
<given-names>Anthony C.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/105440" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yolken</surname>
<given-names>Robert</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3118" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Murray</surname>
<given-names>Robin M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/11930" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pollak</surname>
<given-names>Thomas A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/402976" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>MRC Centre for Neurodevelopmental Disorders, King’s College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Stanley Laboratory of Developmental Neurovirology, Johns Hopkins Medical Center</institution>, <addr-line>Baltimore, MD</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Belinda Lennox, University of Oxford, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Sabina Berretta, McLean Hospital, United States; Teresa Sanchez-Gutierrez, Universidad Internacional De La Rioja, Spain</p>
</fn>
<corresp id="fn001">*Correspondence: Thomas A. Pollak, <email xlink:href="mailto:thomas.pollak@kcl.ac.uk" xlink:type="simple">thomas.pollak@kcl.ac.uk</email>
</corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Schizophrenia, a section of the journal Frontiers in Psychiatry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>72</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Kępińska, Iyegbe, Vernon, Yolken, Murray and Pollak</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Kępińska, Iyegbe, Vernon, Yolken, Murray and Pollak</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Associations between influenza infection and psychosis have been reported since the eighteenth century, with acute “psychoses of influenza” documented during multiple pandemics. In the late 20<sup>th</sup> century, reports of a season-of-birth effect in schizophrenia were supported by large-scale ecological and sero-epidemiological studies suggesting that maternal influenza infection increases the risk of psychosis in offspring. We examine the evidence for the association between influenza infection and schizophrenia risk, before reviewing possible mechanisms <italic>via</italic> which this risk may be conferred. Maternal immune activation models implicate placental dysfunction, disruption of cytokine networks, and subsequent microglial activation as potentially important pathogenic processes. More recent neuroimmunological advances focusing on neuronal autoimmunity following infection provide the basis for a model of infection-induced psychosis, potentially implicating autoimmunity to schizophrenia-relevant protein targets including the N-methyl-D-aspartate receptor. Finally, we outline areas for future research and relevant experimental approaches and consider whether the current evidence provides a basis for the rational development of strategies to prevent schizophrenia.</p>
</abstract>
<kwd-group>
<kwd>infection</kwd>
<kwd>epidemiology</kwd>
<kwd>autoimmunity</kwd>
<kwd>neurodevelopment</kwd>
<kwd>maternal immune activation (MIA)</kwd>
<kwd>influenza</kwd>
<kwd>schizophrenia</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Wellcome Trust<named-content content-type="fundref-id">10.13039/100004440</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">Medical Research Council<named-content content-type="fundref-id">10.13039/501100000265</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn003">Medical Research Council<named-content content-type="fundref-id">10.13039/501100000265</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="237"></ref-count>
<page-count count="19"></page-count>
<word-count count="9062"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction: What Is the Evidence for an Association Between Influenza and Schizophrenia?</title>
<p>Schizophrenia risk is associated with a variety of environmental and genetic factors (<xref ref-type="bibr" rid="B1">1</xref>), including those associated with immunity and inflammation (<xref ref-type="bibr" rid="B2">2</xref>). Genome-wide association studies (GWAS) implicate loci at the major histocompatibility complex (MHC) which encodes multiple genes involved in immunity such as the <italic>human leukocyte antigen</italic> (<italic>HLA</italic>) genes (<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B6">6</xref>) and complement component 4 (C4) (<xref ref-type="bibr" rid="B7">7</xref>), among others, and enhancers related to B-lymphocyte lineages (CD19 and CD20 lines) involved in acquired/adaptive immunity (<xref ref-type="bibr" rid="B8">8</xref>). Overall there is strong evidence supporting the involvement of specific immune variants in schizophrenia risk (<xref ref-type="bibr" rid="B7">7</xref>), some evidence of convergence across genomics, transcriptomic, and methylomic processes (<xref ref-type="bibr" rid="B9">9</xref>), but conflicting evidence for both (i) enrichment of specific immune cell types or pathways (<xref ref-type="bibr" rid="B10">10</xref>) and (ii) for genetic overlap between SZ and specific immune diseases (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>Substantial epidemiological evidence exists suggesting that maternal, perinatal, childhood, and adult infection may all increase the risk of schizophrenia diagnosis (<xref ref-type="bibr" rid="B13">13</xref>–<xref ref-type="bibr" rid="B19">19</xref>). While many organisms and infection types have been implicated in schizophrenia risk, the influenza virus has special status: not only is maternal influenza infection the most well-replicated infective risk factor for schizophrenia, but the history of schizophrenia research has been shaped at crucial points by observations concerning the apparent, sometimes surprising, role of influenza as an exposure. This review aims to present the current state of knowledge on mechanisms by which influenza infection may confer schizophrenia risk, along with the implications of this understanding for future research, prevention, and treatment.</p>
<p>Before the focus of this review moves to schizophrenia and related psychotic disorders, it should be noted that some of the associations that will be discussed are now thought not to be specific to schizophrenia risk. The late winter/spring season of birth effect has also been reported in bipolar disorder (BD) (<xref ref-type="bibr" rid="B20">20</xref>), but the evidence for a link between BD and influenza is somewhat mixed (<xref ref-type="bibr" rid="B21">21</xref>) and addressed in limited studies (<xref ref-type="bibr" rid="B22">22</xref>). Influenza (including serologically documented infection) has been reported as a risk factor for BD with psychotic features but not nonpsychotic BD [reviewed in (<xref ref-type="bibr" rid="B22">22</xref>–<xref ref-type="bibr" rid="B24">24</xref>)]. Furthermore, some evidence suggests an association between maternal infection and autism spectrum disorders (ASD) [reviewed in (<xref ref-type="bibr" rid="B25">25</xref>)]. A substantial body of work from Scandinavian (largely Danish) health register studies supports the notion that clinically diagnosed maternal, childhood, or adulthood infection is a pluripotent risk factor for the subsequent development of psychiatric disorder, with effects observed across diagnostic boundaries (<xref ref-type="bibr" rid="B13">13</xref>–<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). Therefore, while the focus of this review is on schizophrenia and psychosis, the potential transdiagnostic relevance of some of the mechanisms reviewed here should not be ignored.</p>
<p>Currently, influenza is regarded predominantly as a respiratory illness, but before the last century a far broader conceptualisation existed. As early as a 1732 epidemic, clinicians made note of the nervous sequelae of infection, with manifestations including neurasthenia, melancholy, hysteria, mental prostration, and insanity (<xref ref-type="bibr" rid="B28">28</xref>). According to the historian of medicine Mark Honigsbaum: “in the mid-1890s British medical journals were full of tales of Victorian professionals driven to the brink of madness and beyond by the nervous sequelae of influenza… for some 30 years, from the first epidemics of Russian influenza in the 1890s through to the ‘Spanish’ influenza of 1918–19, the ‘psychoses of influenza' were a widely recognised psychiatric phenomenon” (<xref ref-type="bibr" rid="B29">29</xref>). In 1919, Karl Menninger published a now-classic paper reporting the characteristics of 100 patients with mental disturbances associated with influenza infection admitted in a 3-month period to the Boston Psychopathic Hospital. Of 80 on whom full data were available, 16 were diagnosed with delirium, 25 with “dementia praecox,” 23 with “other psychoses,” and 16 were unclassified (<xref ref-type="bibr" rid="B30">30</xref>). Interestingly, two-thirds of the “dementia praecox” patients were reported to have fully recovered at 5-year follow up (<xref ref-type="bibr" rid="B31">31</xref>). A further historically important strand of evidence came from von Economo's (<xref ref-type="bibr" rid="B32">32</xref>) research on encephalitis lethargica (EL), a still poorly understood inflammatory CNS condition featuring psychotic and catatonic symptoms, which was broadly contemporaneous with and potentially aetiologically related to the 1918-1919 Spanish influenza pandemic. <xref ref-type="table" rid="T1">
<bold>Table 1</bold>
</xref> provides an overview of historical influenza pandemics that have been linked to the occurrence of psychosis.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Influenza pandemics and their relationships to psychosis.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Name of influenza pandemic</th>
<th align="center" colspan="1" rowspan="1" valign="top">Dates</th>
<th align="center" colspan="1" rowspan="1" valign="top">Influenza strain involved</th>
<th align="left" colspan="1" rowspan="1" valign="top">Relationship to psychosis</th>
<th align="center" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1889–1892 influenza pandemic (Russian influenza)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1889–1892</td>
<td align="center" colspan="1" rowspan="1" valign="top">H2N2</td>
<td align="left" colspan="1" rowspan="1" valign="top">psychosis, suicidal thoughts, paranoia following infection</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1918 Spanish influenza pandemic</td>
<td align="center" colspan="1" rowspan="1" valign="top">1918–1920</td>
<td align="center" colspan="1" rowspan="1" valign="top">H1N1</td>
<td align="left" colspan="1" rowspan="1" valign="top">delirium, dementia praecox, acute psychosis (<xref ref-type="bibr" rid="B35">35</xref>); encephalitis lethargica (<xref ref-type="bibr" rid="B32">32</xref>) following infection</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B35">35</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Asian influenza pandemic</td>
<td align="center" colspan="1" rowspan="1" valign="top">1957–1958</td>
<td align="center" colspan="1" rowspan="1" valign="top">H2N2</td>
<td align="left" colspan="1" rowspan="1" valign="top">acute psychotic manifestations: anxiety, confusion, restlessness, paranoia, abnormal electroencephalography 2-10 days after influenza onset, (<xref ref-type="bibr" rid="B36">36</xref>); excess of female births with an increased schizophrenia risk five months after the onset of the 1957 epidemic (<xref ref-type="bibr" rid="B37">37</xref>); however, no significant excess of schizophrenia cases in births in the 1959 epidemic (<xref ref-type="bibr" rid="B37">37</xref>);</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B36">36</xref>–<xref ref-type="bibr" rid="B43">43</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2009 influenza pandemic (swine flu)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2009–2010</td>
<td align="center" colspan="1" rowspan="1" valign="top">H1N1</td>
<td align="left" colspan="1" rowspan="1" valign="top">encephalitis, psychosis, including depressive-type psychosis and repetitive transient psychosis in children following infection</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>While suggestive, these reports do not provide evidence of a causal link between influenza infection and psychotic disorders. Renewed interest in the second half of the 20<sup>th</sup> century shifted focus towards maternal infection, following consistent findings of an increased risk for schizophrenia in late winter/spring season births (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B46">46</xref>), raising the possibility of winter-borne infection as a plausible mechanism. Beginning with Mednick et al.'s 1988 study of a Finnish population exposed to the 1957 influenza A2 pandemic, epidemiological studies in the 1980s–1990s, of an ecological nature, described increased risk for schizophrenia in children who were <italic>in utero</italic> during an influenza epidemic (<xref ref-type="bibr" rid="B37">37</xref>–<xref ref-type="bibr" rid="B41">41</xref>). These studies are comprehensively reviewed in (<xref ref-type="bibr" rid="B47">47</xref>). Frequently, rates were highest for second trimester exposures, although the first trimester appeared also to be a period of increased risk. Some subsequent studies however—often with more accurate case ascertainment and larger samples—were not able to replicate these initial findings [e.g. (<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>)]. While estimates of risk varied greatly and heterogeneity in methodology somewhat limits generalisability, a 2010 review calculated that maternal influenza exposure increased schizophrenia risk with an odds ratio of 3.0 and a population attributable proportion of 14% (<xref ref-type="bibr" rid="B47">47</xref>).</p>
<p>Partly because of the manifold methodological problems involved in imputing precisely who was exposed to influenza, these ecological studies were followed by so-called “sero-epidemiological” studies, in which infection was verified using archived biological specimens: in one such early study first trimester maternal exposure was associated with a sevenfold increase in offspring schizophrenia risk, with threefold increase in risk associated with early-to-mid gestation exposure (<xref ref-type="bibr" rid="B50">50</xref>).</p>
<p>Other studies explored whether other viral and bacterial infections are associated with differential schizophrenia risk. A meta-analysis found that childhood viral infection was associated with a nearly twofold increased risk of adult nonaffective psychosis and that of all childhood infections, viral infections in particular, were associated with a nearly twofold increased risk of adult schizophrenia (<xref ref-type="bibr" rid="B18">18</xref>). However, bacterial infections were not associated with risk for psychosis, suggesting that risk may be specific for childhood viral infections.</p>
<p>Some controversy persists as to whether the evidence for maternal influenza as a schizophrenia risk factor is sufficient. A recent review of studies of schizophrenia risk in relation to the 1957 influenza pandemic criticised the serological studies for using strain-specific antibody titres that were too low to be specific for recent infection and so were insufficient as proxy measures of recent infection; furthermore, a pooled meta-analysis of eight ecological studies and one serological study found no overall increased risk of schizophrenia in children of influenza-exposed mothers (<xref ref-type="bibr" rid="B51">51</xref>). This review was in turn criticised as inappropriate given the heterogeneity of methods used in the pooled studies (<xref ref-type="bibr" rid="B52">52</xref>); furthermore it appeared to omit some relevant serological data [e.g. (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>)] and as it focuses on the 1957 pandemic only, it does not include studies on other strains of influenza infection and psychosis.</p>
<p>Complicating interpretation of ecological/epidemiological and serological studies is the fact that obstetric complications are more likely following influenza or influenza-like illness, and that obstetric complications are an independent risk factor for the subsequent development of psychotic disorders and/or symptoms (<xref ref-type="bibr" rid="B53">53</xref>–<xref ref-type="bibr" rid="B55">55</xref>).</p>
<sec id="s1_1">
<title>Reconciling Maternal Infection With Influenza With the Neurodevelopmental Hypothesis of Schizophrenia</title>
<p>The late 1980s and 1990s saw the emergence of neurodevelopmental theories offering mechanistic accounts of how schizophrenia develops. The neurodevelopmental hypothesis (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>) posits that schizophrenia results from a pathological disruption of normal brain development which commences many years before schizophrenia onset (<xref ref-type="bibr" rid="B58">58</xref>). Infection and other insults could disrupt developmental processes such as cell proliferation, cell migration, arborisation, and myelination (<xref ref-type="bibr" rid="B59">59</xref>) with resulting brain structural alterations [e.g. ventricular enlargement, grey matter reductions, and white matter disruption; (<xref ref-type="bibr" rid="B60">60</xref>)]; activation of pathologically developed brain systems in adolescence or young adulthood then manifests in schizophrenia symptoms (<xref ref-type="bibr" rid="B59">59</xref>).</p>
<p>Amongst other criticisms, the theory fails to account for later-onset schizophrenia [45 years or older; (<xref ref-type="bibr" rid="B61">61</xref>)] and postadolescence changes (<xref ref-type="bibr" rid="B62">62</xref>). Extended neurodevelopmental models posited further “hits,” e.g., genetic and environmental factors first predisposing to schizophrenia prenatally and then later in life [“three-hit” model, (<xref ref-type="bibr" rid="B63">63</xref>); multiple hit theory, (<xref ref-type="bibr" rid="B64">64</xref>)]. Infection is a possible “hit”; for instance, human endogenous retrovirus infections, activated by viruses including influenza, were suggested as late “hits” (<xref ref-type="bibr" rid="B64">64</xref>). This theory is consistent with evidence that maternal infection contributes to later increased offspring risk for childhood infections, which in turn contribute to schizophrenia development (<xref ref-type="bibr" rid="B65">65</xref>).</p>
<p>There is no clear evidence that genetic liability to schizophrenia increases the likelihood of influenza infection or predisposes to a disrupted immune response to influenza, or that influenza genetic risk loci are implicated in schizophrenia. In terms of genetic risk for influenza infection, while significant genetic effects accounting for the antibody level in influenza A and B (<xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>) have been reported with <italic>h</italic>
<sup>2</sup> (heritability) range of 0.20–0.27 and <italic>c</italic>
<sup>2</sup> (shared environnment) = 0.19 for influenza A and B (<xref ref-type="bibr" rid="B66">66</xref>), results for discrete serostatus (seropositive/seronegative) were significant for influenza B only. However, another GWAS of IgG response to viruses identified HLA class II residues as causal variants and found an overlap between variants affecting the humoral response to influenza A and variants linked to influenza-related autoimmune disorders including narcolepsy (<xref ref-type="bibr" rid="B68">68</xref>). Neither of these studies nor any others to date have directly addressed the issue of overlap between genetic risk for schizophrenia and specific risk for influenza infection, although this has been explored for other pathogens (<xref ref-type="bibr" rid="B69">69</xref>–<xref ref-type="bibr" rid="B71">71</xref>). A UK population-based cohort study of 7,921 mothers found no association between schizophrenia polygenic risk score (PRS) and perinatal infection (using a single “any infection” category) (<xref ref-type="bibr" rid="B72">72</xref>). Similarly, a case-control study by Benros et al. explored an association between schizophrenia PRS and a history of hospital contacts for viral infections, including influenza infection: PRS for schizophrenia did not account for the association between hospitalisation for infection and subsequent schizophrenia risk, indicating that schizophrenia risk does not increase proneness to such severe infections (<xref ref-type="bibr" rid="B73">73</xref>).</p>
</sec>
</sec>
<sec id="s2">
<title>The Influenza Virus and Potential Pathological Mechanisms Underlying the Association Between Schizophrenia and Influenza Infection</title>
<sec id="s2_1">
<title>Influenza: Structure and Pathophysiology</title>
<p>The influenza virus is an enveloped RNA virus from the family <italic>Orthomyxoviridae</italic>, with three genera, influenza A, B, and C (<xref ref-type="bibr" rid="B74">74</xref>). Given that influenza type A is responsible for pandemics (<xref ref-type="bibr" rid="B75">75</xref>) historically linked to schizophrenia and psychotic symptoms (see <xref ref-type="table" rid="T1">
<bold>Table 1</bold>
</xref>), we will focus on this alone. Influenza A viruses are classified into subtypes based on the antigenic properties of their envelope glycoproteins (see <xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>), hemagglutinin, and neuraminidase. The viral envelope is a lipid membrane derived from plasma membrane of an infected host cell. Influenza strain targets also differ. Notably, the H5N1 virus and other avian-derived strains are neurotropic while H1N1 is thought not to be (<xref ref-type="bibr" rid="B76">76</xref>–<xref ref-type="bibr" rid="B78">78</xref>).</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>Structure of the influenza virus.</p>
</caption>
<graphic xlink:href="fpsyt-11-00072-g001"></graphic>
</fig>
<p>For infection to be successful, hemagglutinin binds the influenza virus to its receptors, sialyloligosaccharides, on the host cell surface. The viral envelope and the host cell membrane fuse giving the viral RNA access to the host cell (<xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B79">79</xref>). Neuraminidase facilitates virus release (<xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>). Following the production of viral particles in the nucleus of the host cell, the host cell lyses and dies (<xref ref-type="bibr" rid="B75">75</xref>). Protective immune responses from the cell occur; the viral hemagglutinin, neuraminidase, and matrix 2 (M2) proteins are targeted by antibodies; matrix 1 (M1) proteins are targeted by T cells (<xref ref-type="bibr" rid="B80">80</xref>); and nucleoproteins are targeted by T cells (<xref ref-type="bibr" rid="B80">80</xref>) and nonneutralizing antibodies (<xref ref-type="bibr" rid="B81">81</xref>).</p>
</sec>
<sec id="s2_2">
<title>Experimental Paradigms of <break></break>Maternal Infection</title>
<p>While maternal infection is reported to be a risk factor for schizophrenia, controversy remains concerning which biological processes underlie this risk. There is scant evidence for transplacental passage and persistence of the influenza virus in the offspring brain (<xref ref-type="bibr" rid="B82">82</xref>). More likely to be relevant are the effects of infection-induced maternal immune activation (MIA) on the developing brain (<xref ref-type="bibr" rid="B83">83</xref>).</p>
<p>MIA cannot be easily modelled in humans and longitudinal, prospective research on effects of infection during pregnancy on human development is scarce (<xref ref-type="bibr" rid="B84">84</xref>). Hence, translational animal models of MIA have been developed: these models have been critical in providing causality to the epidemiological data and are starting to provide clues as to the cellular and molecular mechanisms that may underlie the associations (<xref ref-type="bibr" rid="B83">83</xref>). Rodents in gestational periods are exposed either directly to a pathogen such as influenza, or more commonly to nonvirulent immune-activating agents such as the viral mimetic polyriboinosinic-polyribocytidilic acid (poly(I:C)) or the bacterial endotoxin lipopolysaccharide (LPS), the inflammatory agent turpentine, or specific proinflammatory cytokines (<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B85">85</xref>). These animal models of MIA provide evidence for behavioral, neurochemical, neuroanatomic, and neurophysiologic disruptions in the offspring which map onto endophenotypes observed across human psychiatric disorders with a neurodevelopmental onset (<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B86">86</xref>). Such translational research complements the insights from human epidemiology by establishing causal relationships, identifying cellular and molecular mechanisms and offering the potential to explore therapeutic interventions (<xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B86">86</xref>). Frequently, these aforementioned deficits in the MIA model demonstrate a maturational delay, such that they are not evident before young adulthood, and many studies have sought to mitigate these deficits with treatments (e.g., pharmacological, immunological, behavioral) (<xref ref-type="bibr" rid="B83">83</xref>). Another important etiological advance for such animal models is to recapitulate a “two-hit” approach, in which pathology becomes evident in MIA-exposed offspring only after a second hit, such as unpredictable psychological stress (<xref ref-type="bibr" rid="B87">87</xref>).</p>
<p>MIA may lead straightforwardly to damage to the foetal brain during the early stages of neurodevelopment (<xref ref-type="bibr" rid="B82">82</xref>), but may also provide entry into a deviant trajectory of neural development which predisposes offspring to behavioral deficits depending on the intensity of the infection and when in gestation it occurs [early vs. late—and potentially as late as the lactation stage (<xref ref-type="bibr" rid="B88">88</xref>)]. MIA-associated abnormalities have been described, sometimes inconsistently, for multiple brain cell types, all of which are implicated across psychiatric disorders from postmortem data and genetic studies to a greater or lesser extent: Schwann cells (<xref ref-type="bibr" rid="B89">89</xref>), astrocytes and microglia (<xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B91">91</xref>), hippocampal GABAergic cells (<xref ref-type="bibr" rid="B92">92</xref>, <xref ref-type="bibr" rid="B93">93</xref>), dopaminergic neurons (<xref ref-type="bibr" rid="B94">94</xref>), and parvalbumin interneurons (<xref ref-type="bibr" rid="B95">95</xref>, <xref ref-type="bibr" rid="B96">96</xref>).</p>
<p>Notably, most rodent (and primate) MIA models use a dose of poly(I:C) which models a high intensity, acute and transient (&lt;24 h) infection, the physiological relevance of which could be questioned. Furthermore, factors such as the source, molecular weight, and endotoxin contamination of experimental poly(I:C) may be unrecognised sources of variability in foetal outcomes (<xref ref-type="bibr" rid="B97">97</xref>). Although MIA models specifically using pathogens as the immune activating stimulus have become rarer in recent years, primarily due to increasingly stringent safety frameworks around the use of potentially virulent pathogens (<xref ref-type="bibr" rid="B98">98</xref>), a series of MIA studies using human H1N1 influenza infection by the group of S. Hossein Fatemi are particularly valuable in elucidating potential mechanisms of psychosis risk. Broadly, maternal human H1N1 infection has been demonstrated to cause abnormalities, within the offspring, of the following [summarized in (<xref ref-type="bibr" rid="B99">99</xref>) and (<xref ref-type="bibr" rid="B59">59</xref>)]:</p>
<p>
<italic>Gene Expression</italic>: the breadth of gene expression changes was greater the later in embryonic development infection occurred; for example embryonic day 16 or 18 (E16 or E18) infection disrupted more genes, across more brain regions, than did E7 infection. Furthermore, infection at later embryonic stages disrupted expression of genes involved in myelination and implicated in schizophrenia risk.</p>
<p>
<italic>Protein Expression:</italic> increase in production of potentially harmful neuronal nitric oxide synthase (nNOS), reduction of reelin expression indicating abnormal neuronal migration and decreased synaptic plasticity, and downregulation of myelin basic protein.</p>
<p>
<italic>Brain Structure:</italic> reduced cerebral cortical volume; increased total brain volume after early embryonic infection, decreased total brain volume after late infection.</p>
<p>
<italic>Behavior:</italic> decreased prepulse inhibition (PPI), increased head twitch response.</p>
<p>
<italic>Neurotransmitter Levels:</italic> reduced serotonin and taurine levels.</p>
<p>
<italic>Placental Development:</italic> increased cytoarchitectural disorganisation, increased presence of immune cells, presence of variously sized thrombi, and dysregulation of placental gene expression.</p>
<p>Additional selected studies, focused on models of infection with influenza virus, are presented in <xref ref-type="table" rid="T2">
<bold>Table 2</bold>
</xref>.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Summary of selected behavioral and pathological outcomes following influenza infection in rodents.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Study</th>
<th align="center" colspan="1" rowspan="1" valign="top">Year</th>
<th align="center" colspan="1" rowspan="1" valign="top">Influenza virus type</th>
<th align="center" colspan="1" rowspan="1" valign="top">Animal</th>
<th align="left" colspan="1" rowspan="1" valign="top">Animal infected</th>
<th align="left" colspan="1" rowspan="1" valign="top">Age of animal at assessment</th>
<th align="left" colspan="1" rowspan="1" valign="top">Behavioral <break></break>and physical <break></break>outcomes</th>
<th align="left" colspan="1" rowspan="1" valign="top">Pathological outcomes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cotter et al. (<xref ref-type="bibr" rid="B100">100</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">1995</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/Singapore/1/57 (H2N2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice between day 9-16 of pregnancy </td>
<td align="left" colspan="1" rowspan="1" valign="top">Offspring 21 days postpartum</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">No excess pyramidal cell disarray when compared with influenza-free, age-matched controls. Cell disarray greater among mice exposed on day 13 of pregnancy </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B101">101</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">1998</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neonate pups at postnatal day 0 (P0; day of delivery)</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased expression of membrane protein synaptosome-associated protein 25 kDa [SNAP-25), a presynaptic neuronal marker in the neonatal brain: 40%–347% over control in most septal–dorsal hippocampal layers; 10%–114% over control in all mid septo-temporal hippocampus layers, except for the hippocampal plate; but SNAP-25 expression was reduced in all temporal–ventral levels, infected layers by 21%–33% below control except for mild increases of 8.8% and 10% in subplate and hippocampal plate layers</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B102">102</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">1999</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neonate pups at P0</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Changes influencing levels of reelin, a protein responsible for normal lamination of the brain. Significant reductions in reelin-positive cell counts in layer I of neocortex and other cortical and hippocampal layers. Layer I Cajal–Retzius cells produced significantly less reelin. Decreases in neocortical and hippocampal thickness</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B103">103</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2000</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adolescent offspring (P35) and young adults (P56)</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Changes in the levels of neuronal nitric oxide synthase (nNOS) involved in synaptogenesis and excitotoxicity: increase of 147% in nNOS levels in the brain at P35, with an eventual 29% decrease on P56. Reductions in nNOS in middle and caudal brain areas on P35 and P56.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Aronsson et al. (<xref ref-type="bibr" rid="B104">104</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2001</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Four-week-old <italic>Tap1</italic> (antigen peptide transporter 1) gene knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">7 days and 10, 12, and 17 months p.i.</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Viral RNA encoding the nonstructural NS1 protein was detected in sections at midbrain levels in most animals. Negative-strand genomic RNA and positive-strand RNA, including mRNA, were found. RNA encoding nucleoprotein and polymerases, which form the replicative complex of the virus, were detected in fewer brains. RNA encoding envelope proteins were found only in occasional brains. No viral cDNA could be identified</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Aronsson et al. (<xref ref-type="bibr" rid="B82">82</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2002</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 14 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Foetuses at pregnancy day 17; offspring 10, 20, 35, 60, and 90 days of age</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Viral RNA encoding matrix and/or nucleoprotein detected in a proportion of foetal brains and lungs, viral RNA detected in some placentas. RNA persisted for at least 90 days of postnatal life</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B105">105</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2002</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Offspring at P0, P14 and P35</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered expression of glial fibrillary acidic protein (GFAP), a marker of gliosis, neuron migration, and reactive injury: increases in GFAP-positive density in exposed cortical and hippocampal cells; ependymal cell layer GFAP-IR cell counts showed increases with increasing brain age from P0 to P14 and P35 in infected groups. The GFAP-positive cells in showed ‘hypertrophy' and more stellate morphology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B106">106</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2002</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neonates at P0 and 14-week-old offspring</td>
<td align="left" colspan="1" rowspan="1" valign="top">One exposed group with deficient prepulse inhibition (PPI), one group did not show abnormal PPI</td>
<td align="left" colspan="1" rowspan="1" valign="top">The rate of pyramidal cell proliferation per unit area decreased from birth to adulthood in both control and exposed groups, nonpyramidal cell growth rate increased only in the exposed adult mice</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Shi et al. (<xref ref-type="bibr" rid="B107">107</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2003</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33CHINI (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9.5 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult offspring</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deficient PPI; deficient responses to acute administration of clozapine, chlorpromazine and ketamine; deficient exploratory behavior in open-field and novel-object tests; deficient social interaction</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Asp et al. (<xref ref-type="bibr" rid="B108">108</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2005</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 14 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Offspring sampled at E17 and sex-matched animals on P35, P60, and P90</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Levels of transcripts encoding neuroleukin and fibroblast growth factor 5 were significantly elevated in the brains of the virus-exposed offspring at 90 and 280 days of age, but not at earlier time-points. For neuroleukin, this difference could also be observed at the protein level</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B109">109</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2005</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Newborn offspring</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Significant upregulation of 21 genes and downregulation of 18 genes in brains of day 0 exposed offspring, including genes involved in signal transduction/cell communication, solute transport, protein metabolism, energy metabolism, nucleic acid metabolism, immune response, and cell growth and maintenance</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Asp et al. (<xref ref-type="bibr" rid="B110">110</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2007</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Newborn offspring infected on P3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Newborn offspring on P3; whole brains were sampled at: embryonal day (E)17 and P7, P13, and P24. From two animals, the hippocampus, cortex, and cerebellum were dissected from freshly prepared brains at P3, P10, P15, and P27</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased levels of transcripts encoding Gcm1 and syncytin B, but not syncytin A, in NIH-3T3 cells as well as in mouse primary neurons or glia. Overexpression of human GCM1 in NIH-3T3 cells resulted in increased levels of transcripts encoding syncytin B<break></break>but not syncytin A. Systemic administration of neurotropic influenza A virus<break></break>resulted in a neuronal infection and increased levels of Gcm1-encoding transcripts in brains of young mice</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B111">111</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2008</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 18 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Male offspring tested at birth (P0), childhood (P14), adolescence (P35), and young adulthood (P56)</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered gene expression of Sema3a, Trfr2 and Vldlr and altered protein levels of Foxp2. Embryonic day 18 mother infection led to significant gene alterations in frontal, hippocampal and cerebellar cortices of developing offspring. Significant atrophy in several brain areas and white matter thinning in corpus callosum. Altered levels of serotonin (P14, P35), 5-Hydroxyindoleacetic acid (P14) and taurine (P35)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B112">112</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2008</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Offspring tested at birth (P0), childhood (P14), adolescence (P35), and young adulthood (P56)</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Changes in mRNA and protein levels of nucleolin, aquaporin 4, and connexin 43 (markers involved in ribosomal RNA transcription, potentially viral replication, water transport, and changes in brains of subjects with autism): nucleolin mRNA and aquaporin 4 significantly decreased in neocortex at P0 and P35. Protein levels were significantly upregulated at P35 and P56 in neocortex and P56 in cerebellum<break></break>Microcephalin mRNA was significantly decreased in neocortex at P56 and protein levels were significantly decreased at P56 in the cerebellum</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B113">113</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2008</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 16 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Offspring at P35 and P56</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Twofold or greater upregulation of 103 genes and downregulation of 102 genes in cerebellum at P35. Twofold or greater upregulation of 27 genes and downregulation of 23 genes in the cerebellum at P56. Genes with their regulation disrupted are involved in cell growth and/or maintenance, channel proteins, membrane receptors, signalling, and transcription regulation, among other functions</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Holtze et al. (<xref ref-type="bibr" rid="B114">114</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2008</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice infected at infected at P3 or P4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Whole brains from both sexes sampled at P7, P13, or P24</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered levels of transcripts encoding several key enzymes of the kynurenine pathway observed in the brain on P7 and P13 but not on day P24. On P13, infiltrating T lymphocytes and increased levels of kynurenic acid in the brains of the infected animals</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Winter et al. (<xref ref-type="bibr" rid="B115">115</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2008</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 16 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Male offspring tested at P0, P14, P35, and P56</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">A significant decrease in serotonin levels in the cerebella of offspring of virally exposed mice at P14. No differences in dopamine levels between exposed and control mice. A significant decrease in dopamine at P14 and P56 compared to P0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Asp et al. (<xref ref-type="bibr" rid="B116">116</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2009</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wild-type mice and <italic>Tap1</italic> gene knockout mice infected at P3 or P4</td>
<td align="left" colspan="1" rowspan="1" valign="top">3–4-months-old male mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infected <italic>Tap1</italic> gene knockout mice, but not wild type mice, exhibited deficits in working memory, increased rearing activity, and anxiety</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced levels of type III <italic>Nrg1</italic> transcripts in the medial prefrontal cortices of <italic>Tap1</italic> gene knockout mice were observed. The lack of CD8<sup>+</sup> T cells appeared to contribute to a more pronounced glia response in <italic>Tap1</italic> gene knockout mice than in wild-type mice</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Shi et al. (<xref ref-type="bibr" rid="B117">117</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2009</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33CHINI (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9.5 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult offspring and offspring 11 days of age</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Purkinje cells deficit in the cerebellum</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B118">118</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2009</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 16 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Male offspring tested at P0, P14, P35, and P56</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered expression of myelination-related genes, including <italic>Mbp</italic>, <italic>Mag</italic>, and <italic>Plp1</italic>, and altered levels of proteins Mbp, Mag, and DM20. Significant atrophy in cerebellum at P14, reduced fractional anisotropy in white matter of the right internal capsule at P0, increased fractional anisotropy in white matter in corpus callosum at P14 and right middle cerebellar peduncle at P56</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B119">119</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2009</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 16 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Male offspring tested at P0, P14, P35, and P56</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered gene expression in the hippocampus at P0, P14, and P56 including <italic>Aqp4</italic>, <italic>Mbp</italic>, <italic>Nts</italic>, <italic>Foxp2</italic>, <italic>Nrcam</italic>, and <italic>Gabrg1</italic>. Downregulation of myelination genes <italic>Mag</italic>, <italic>Mog</italic>, <italic>Mobp</italic>, <italic>Mal</italic>, and <italic>Plp1</italic> at P0. Reduction in hippocampal volume at P35</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Asp et al. (<xref ref-type="bibr" rid="B120">120</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2010</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wild-type mice and <italic>Tap1</italic> gene knockout mice infected at P3 or P4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Male mice at age 5–6 months tested for PPI; whole brains of the <italic>Tap1</italic> gene knockout mice sampled at P7, P13, and P24 to explore the kynurenine pathway</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tap1 gene knockout mice, but not wild-type mice, exhibited a reduction in PPI at 5–6 months of age</td>
<td align="left" colspan="1" rowspan="1" valign="top">Levels of several transcripts in the kynurenine pathway altered at P7, P13 and P24. Transcripts encoding indoleamine-pyrrole 2,3-dioxygenase (IDO), degrading tryptophan in the first step of the kynurenine pathway were consistently up-regulated</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Moreno et al. (<xref ref-type="bibr" rid="B121">121</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2011</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 9.5 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adult offspring (10–12 weeks of age)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased head-twitch response to hallucinogens, diminished antipsychotic-like effect of the glutamate agonist</td>
<td align="left" colspan="1" rowspan="1" valign="top">In frontal cortex, the upregulated 5-HT(2A) receptor and the downregulated mGlu(2) receptor. The cortical 5-HT(2A) receptor-dependent signalling pathways altered, showing higher c-fos, egr-1, and egr-2 expression in response to the hallucinogenic drug DOI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Landreau et al. (<xref ref-type="bibr" rid="B94">94</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2012</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/New Caledonia/20/99-like (H1N1) (A/NC-L/99), A/Sydney/5/97-like (H3N2) (A/Sy-L/97), A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rats and mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Primary cultures of rat mesencephalon infected after day 14 of pregnancy; mothers on day 9–11 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurons from rat embryos recovered at day 14 of pregnancy; offspring of mice infected in pregnancy tested at 30 and 90 days of age</td>
<td align="left" colspan="1" rowspan="1" valign="top">The A/WSN/33 strain associated with greater behavioral impairment (exploration, novel objects, and spontaneous activity) than A/NC-L/99.<break></break>Offspring of mother infected with both influenza virus strains showed behavioral abnormalities in exploration, anxiety and working memory. Behavioral alterations emerged in different neurodevelopmental stages depending on the strain, appearing in adult life in offspring of mothers infected with A/NC-L/99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Selective loss of dopaminergic neurons. H1N1 strains had the greatest affinity for dopaminergic neurons, an H3N2 strain induced apoptosis preferentially in other cell types and did not result in NFkB activation.<break></break>Only following the H1N1 strains infection a selective loss of dopaminergic neurons in substantia nigra pars compacta and ventral tegmental area of the offspring. Loss of dopaminergic neurons more pronounced in the adult offspring of mothers infected with the neuroadapted A/WSN/33 than with the respiratory strain A/NC-L/99</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B122">122</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2012</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/WSN/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 7 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Placentae of pregnant mice; male offspring tested at P0, P14, P35, and P56</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Upregulation of 77 genes and significant downregulation of 93 genes in placentas. Changes in gene expression in prefrontal cortex (6 upregulated and 24 downregulated at P0; 5 upregulated and 14 downregulated at P56) and hippocampus (4 upregulated and 6 downregulated at P0; 6 upregulated and 13 downregulated at P56) of exposed offspring. Placentas from infected mice with morphological abnormalities including presence of thrombi and increased presence of immune cells. No H1N1 viral-specific genes for M1/M2, NA, and NS1 in placentas of infected mice and brains of exposed offspring</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fatemi et al. (<xref ref-type="bibr" rid="B123">123</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2017</td>
<td align="left" colspan="1" rowspan="1" valign="top">A/NWS/33 (H1N1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mice on day 16 of pregnancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Male offspring tested at P0, P14, P35, and P56</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Changes in proteins FMRP, VLDLR, GAD65, and GAD67 in cerebella of exposed offspring on specific postnatal dates which implies disrupted FMRP, glutamatergic, and Reelin signalling leading to developmental abnormalities</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Other animal studies have demonstrated associations between maternal influenza infection and schizophrenia-related neurotransmitter dysfunction including elevated serotonin 5-HT2A receptor expression in the frontal cortex (<xref ref-type="bibr" rid="B121">121</xref>), reductions of cerebellar serotonin levels at postpartum days (P) 14 and P35 (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B115">115</xref>), downregulation of the metabotropic glutamate receptor 2 in the frontal cortex (<xref ref-type="bibr" rid="B121">121</xref>), and decrease in dopamine levels at P14 and P56 (<xref ref-type="bibr" rid="B115">115</xref>). Changes following poly(I:C) MIA exposure included subtle metabolic perturbations of postnatal prefrontal cortex maturation (<xref ref-type="bibr" rid="B124">124</xref>), and dynamic changes in volumes of multiple brain structures (<xref ref-type="bibr" rid="B125">125</xref>), including adult changes which can be prevented by periadolescent administration of antipsychotic medication (at nonantipsychotic dose equivalents) (<xref ref-type="bibr" rid="B126">126</xref>). Supporting the translational relevance of these studies, there is an emerging parallel literature in humans suggesting that early immune activation affects subsequent brain development and behavior: for example, maternal IL-6 levels during pregnancy predicted greater neonatal amygdala volumes and connectivity, which in turn predicted poorer impulse control at two years of age (<xref ref-type="bibr" rid="B127">127</xref>); complementary results for amygdala connectivity and internalizing behaviors have been reported for maternal cortisol levels (<xref ref-type="bibr" rid="B128">128</xref>).</p>
<p>An important mediator of the maternal immune response to infection is likely to be disruption of cytokines regulating brain development. Notably maternal infection could dysregulate cytokine networks either by direct transplacental transfer of cytokines to the foetus, by placental cytokine production or by increased foetal production of cytokines, including within the CNS (<xref ref-type="bibr" rid="B129">129</xref>). Cytokine dysregulation can result in perturbations of both proinflammatory and antiinflammatory cytokines. The deleterious or protective effects of any individual cytokine are likely determined by its context within a network of proinflammatory and antiinflammatory mediators, dynamically responding to external and endogenous challenges with differential expression in different brain regions over time (<xref ref-type="bibr" rid="B130">130</xref>). For example, macrophage-driven expression of antiinflammatory IL-10 in a mouse model can attenuate the long-term effects of prenatal viral infection, but in the absence of inflammatory stimulus, IL-10 itself precipitates offspring behavioral abnormalities (<xref ref-type="bibr" rid="B131">131</xref>).</p>
<p>Cytokines are induced in response to inflammation by neurons, astrocytes, and microglia, with the role of activated microglia in schizophrenia pathogenesis being the object of much recent attention (<xref ref-type="bibr" rid="B132">132</xref>). MIA exposure leads to alterations of the microglial transcriptome, with an initial shift to a more reactive state proximal to the MIA insult, followed by a delay in the maturation of brain microglia, as compared to controls (<xref ref-type="bibr" rid="B133">133</xref>). Alterations in the microglial transcriptome also lead to phagocytic function abnormalities and behavioral abnormalities in the adult MIA offspring (<xref ref-type="bibr" rid="B134">134</xref>). Results from the MIA literature are heterogenous with regards to microglial activation in offspring (<xref ref-type="bibr" rid="B91">91</xref>). Some studies report increased microglial density [e.g. (<xref ref-type="bibr" rid="B135">135</xref>)], morphology [e.g. (<xref ref-type="bibr" rid="B136">136</xref>)] or expression of activation markers [e.g. (<xref ref-type="bibr" rid="B137">137</xref>)], while other studies using late MIA have failed to demonstrate long-term changes in microglia density, morphology, or activation (<xref ref-type="bibr" rid="B138">138</xref>). Inference regarding the translational relevance of these findings, too, has been limited by a lack of clarity around the utility of the putative human markers of microglial activation such as translocator protein (TSPO), bound by ligands in Positron Emission Tomography (PET) studies, and of microglial markers used in post-mortem studies; notably, in addition to microglia, both astrocytes and vascular endothelial cells show dynamic changes in TSPO expression in response to inflammatory stimuli, and in a mouse model schizophrenia-relevant behavioral abnormalities and increased inflammatory cytokine expression were associated with reduced, rather than increased, prefrontal TSPO levels (<xref ref-type="bibr" rid="B139">139</xref>).</p>
<p>Both neurotropic and nonneurotropic influenza strains can cause microglial activation and potentially contribute to inflammation (<xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B77">77</xref>). Innate immune training against influenza confers protection against infection with antiviral interferon-stimulated defence genes, including <italic>MXA</italic> (prevents nuclear import of the virus), <italic>IFITM3</italic> and other <italic>IFITM</italic> proteins (block host-virus cell membrane fusion), and viperin [blocks influenza virus release; (<xref ref-type="bibr" rid="B140">140</xref>)]. Innate immune training also promotes disease tolerance of host tissues (<xref ref-type="bibr" rid="B140">140</xref>) and previous activation primes microglia to respond strongly to a new stimulus (<xref ref-type="bibr" rid="B141">141</xref>). Previous neuropathology potentially attunes microglia to respond more strongly to systemic inflammation (<xref ref-type="bibr" rid="B142">142</xref>), including inflammation by chronic mild stress in periadolesence following MIA (<xref ref-type="bibr" rid="B86">86</xref>). Consequently, infection could prime microglia towards heightened activation, potentially increasing the risk of developing psychotic symptoms (<xref ref-type="bibr" rid="B143">143</xref>); alternatively, the opposite could be true, i.e., that the microglia become tolerant and as such cannot respond flexibly to new stimuli.</p>
<p>In terms of potential downstream consequences of such foetal microglial activation, there is an emerging literature implicating the role of microglia in shaping brain development, including the potential for synaptic pruning <italic>via</italic> the full or partial engulfment [phago- or trogocytosis (<xref ref-type="bibr" rid="B144">144</xref>)] and putative degradation of synaptic inputs, a process mediated at least in the rodent visual thalamus in a complement and activity-dependent manner (<xref ref-type="bibr" rid="B145">145</xref>), which may also involve other molecular mediators such as TREM2 for example or the fractalkine receptor [CX3CR1; (<xref ref-type="bibr" rid="B146">146</xref>)] [potential mechanisms are reviewed in (<xref ref-type="bibr" rid="B147">147</xref>)]. Given the well-replicated finding of reduced dendritic spine number in schizophrenia (<xref ref-type="bibr" rid="B148">148</xref>), and evidence that patient-derived microglia-like cells are capable of synapse elimination at least <italic>in vitro</italic> (<xref ref-type="bibr" rid="B149">149</xref>), it is plausible also that maternal infection-induced foetal microglial activation could lead to later psychopathology through upregulation of synaptic pruning mechanisms (or conversely, loss of them: for example, early in development, microglia contact of neurons actually stimulates dendritic spine formation (<xref ref-type="bibr" rid="B150">150</xref>) suggesting the underexplored possibility that different pathologies play out in a potentially time- and region-specific manner).</p>
<p>Additionally, influenza infection may lead to placental abnormalities that result in hypoxia and/or nutritional deficiency or foetal brain growth restriction (<xref ref-type="bibr" rid="B122">122</xref>). Brain abnormalities may also stem from the maternal immune response whereby maternal autoantibodies are transported <italic>via</italic> the placenta and interact with foetal brain antigens to disrupt brain development [the teratogenic antibody hypothesis of schizophrenia; (<xref ref-type="bibr" rid="B151">151</xref>–<xref ref-type="bibr" rid="B153">153</xref>)]. The concept of infection-induced brain autoimmunity is explored in the next section.</p>
</sec>
</sec>
<sec id="s3">
<title>Influenza and Autoimmunity</title>
<p>Research on autoimmune disorders and schizophrenia dates to the 1950s, when schizophrenia was found to be protective against the development of rheumatoid arthritis (<xref ref-type="bibr" rid="B154">154</xref>, <xref ref-type="bibr" rid="B155">155</xref>). Subsequently, the cooccurrence of schizophrenia with celiac disease was noted [e.g. (<xref ref-type="bibr" rid="B156">156</xref>)]. Recent meta-analysis suggests a positive association between nonneurological autoimmune disorders and psychosis (<xref ref-type="bibr" rid="B157">157</xref>). The risk for developing schizophrenia in people with autoimmune disorders was found to increase in association with increasing number of hospitalisations for infections (<xref ref-type="bibr" rid="B158">158</xref>), suggesting a synergistic effect. Drawing on the clinical observation that patients with autoantibody-mediated encephalitis frequently presented with psychosis (<xref ref-type="bibr" rid="B159">159</xref>), serological research has reported the presence of these same autoantibodies against cell surface neuronal antigens in some patients with schizophrenia [e.g. (<xref ref-type="bibr" rid="B160">160</xref>, <xref ref-type="bibr" rid="B161">161</xref>)]. An extensive literature also focuses on markers of previous infection (usually IgG antibodies to specific pathogens, including influenza) in adults with psychotic disorders, with exposure to several organisms associated with increased schizophrenia risk or risk for a specific psychosis symptom profile (e.g. impaired cognition) (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B162">162</xref>).</p>
<sec id="s3_1">
<title>Viral infection, Neuronal Surface Autoantibodies and Psychosis: Anti-NMDAR Encephalitis as a Model of Autoimmune Psychosis With Potential Infective Antecedents</title>
<p>Autoimmune encephalitis (AE) frequently presents with acute psychosis in adults (<xref ref-type="bibr" rid="B163">163</xref>, <xref ref-type="bibr" rid="B164">164</xref>). Autoantibodies to a variety of CNS cell surface antigens (neuronal surface autoantibodies; NSAbs) have been implicated in AE, including the NMDAR and more rarely LGI1, CASPR2, AMPAR, GABA<sub>A</sub>R, GABA<sub>B</sub>R, D2R, DPPX, mGluR5, and GlyR (<xref ref-type="bibr" rid="B165">165</xref>–<xref ref-type="bibr" rid="B169">169</xref>). Of the autoimmune encephalitides associated with the above antigens, NMDAR encephalitis presents most frequently with psychosis. The typical pattern includes prodromal malaise, or influenza-like symptoms, before the emergence of psychiatric symptoms. 4% of patients show isolated psychotic episodes at presentation or relapse (<xref ref-type="bibr" rid="B170">170</xref>) and behavioral and cognitive impairments including psychosis are predominant early symptoms (<xref ref-type="bibr" rid="B171">171</xref>). The psychosis reported in anti-NMDAR encephalitis is distinctive, polymorphic (with significant affective elements) and does not correspond clearly to currently existing categories of psychotic disorder in mainstream psychiatric use (<xref ref-type="bibr" rid="B172">172</xref>). Anti-NMDAR encephalitis is caused by IgG antibodies directed against an epitope on the N-terminal domain of the NR1 subunit of the NMDA glutamate receptor (<xref ref-type="bibr" rid="B173">173</xref>, <xref ref-type="bibr" rid="B174">174</xref>), with intrathecal antibody production by B lymphocyte descendants thought to be essential for pathogenesis.</p>
<p>Anti-NMDAR encephalitis is associated with ovarian teratoma in under a third of cases. An intriguing association between infection and the development of the disorder became apparent when it was observed that a number of patients experiencing “relapses” following herpes simplex virus (HSV) encephalitis had cerebrospinal fluid (CSF) NMDAR antibodies, suggesting that these “relapses” were in fact a postinfectious AE, rather than the result of reinfection or viral reactivation (<xref ref-type="bibr" rid="B175">175</xref>). Subsequent work has established that NMDAR antibody production can occur following HSV encephalitis even in the absence of clear “relapse” or encephalopathy (<xref ref-type="bibr" rid="B176">176</xref>), and that nonencephalitic HSV infection is also more common in patients with anti-NMDAR encephalitis (<xref ref-type="bibr" rid="B177">177</xref>). Other viral pathogens—including Epstein Barr Virus, Human Herpesvirus 6, cytomegalovirus, adenovirus and HIV—have been implicated in this and other autoimmune encephalitides [including those characterized by antibodies to the GABA<sub>A</sub> and GABA<sub>B</sub> receptors, the AMPA receptor and the dopamine D2 receptor; reviewed in (<xref ref-type="bibr" rid="B178">178</xref>)].</p>
<p>A potential association between anti-NMDAR encephalitis and influenza is supported by reports of at least five patients who developed the disorder following influenza vaccination (<xref ref-type="bibr" rid="B179">179</xref>–<xref ref-type="bibr" rid="B182">182</xref>)—although in none of these cases can causation be proven. A phylogenetic relationship has been suggested between microRNAs related to anti-NMDAR encephalitis and the H1N1 influenza virus, with some authors suggesting a theoretical basis for the possibility that anti-NMDAR encephalitis could be induced by influenza vaccination [(<xref ref-type="bibr" rid="B183">183</xref>); see also next section].</p>
<p>Anti-NMDAR encephalitis shares clinical features with EL in children, and indeed NMDAR antibodies have been reported in children with contemporary EL (<xref ref-type="bibr" rid="B184">184</xref>). When considered in the light of classic research on EL following the 1918-1919 Spanish influenza pandemic (<xref ref-type="bibr" rid="B32">32</xref>), this suggests a potential relationship between influenza infection, NSAbs and psychosis in anti-NMDAR encephalitis. [The association between influenza and EL is, however, highly controversial, not least because of temporal and geographical discrepancies between the start of the pandemic and the first recorded EL cases, as well as studies on post-mortem tissue which have frequently failed to find evidence of influenza virus; but given historical issues with case ascertainment and storage of biological samples potentially undermining efforts at viral detection, the association remains a plausible hypothesis for some authors (<xref ref-type="bibr" rid="B185">185</xref>)].</p>
<p>This interpretation is supported by findings that anti-NMDAR encephalitis may be seasonal, with a peak in incidence during winter (<xref ref-type="bibr" rid="B186">186</xref>), potentially converging with seasonality of influenza. Recent research found that Māori and Pacific Island populations have higher incidence and potentially more severe outcomes of anti-NMDAR encephalitis, a finding of significance given that population's apparent increased susceptibility to severe influenza infection (<xref ref-type="bibr" rid="B187">187</xref>, <xref ref-type="bibr" rid="B188">188</xref>).</p>
<p>NMDAR antibodies are of interest in schizophrenia because of their links to the glutamate/NMDAR hypofunction hypothesis of psychotic disorders: NMDAR antibodies found in patients with schizophrenia can disrupt NMDAR dynamics <italic>in vivo</italic> (<xref ref-type="bibr" rid="B189">189</xref>, <xref ref-type="bibr" rid="B190">190</xref>) providing <italic>prima facie</italic> support for the NMDAR hypofunction hypothesis. Crucially, Hammer et al. (<xref ref-type="bibr" rid="B191">191</xref>) reported the presence of influenza virus A or B IgG was significantly associated with NMDAR antibody seropositivity in a large cohort of adult patients with psychotic disorders and disease and healthy controls, a finding that was subsequently replicated in an independent cohort (<xref ref-type="bibr" rid="B192">192</xref>).</p>
</sec>
<sec id="s3_2">
<title>Acquired Neuronal Autoimmunity and Its Relevance to the Maternal Exposure Model</title>
<p>As described above, infection-induced neuronal autoimmunity may have relevance for some acute psychoses. However neuronal autoimmunity also has relevance in the context of maternal transmission. Maternal-foetal transfer of pathogenic antibodies has long been proposed as a potential mechanism in the development of ASD and, to a lesser extent, for schizophrenia also (<xref ref-type="bibr" rid="B153">153</xref>). Although not formally regarded as part of the MIA paradigm, recent animal models have had some successes in recapitulating neurodevelopmental phenotypes in immunisation paradigms whereby maternal antibodies are transferred to the offspring, resulting in neuropathological and behavioral abnormalities (<xref ref-type="bibr" rid="B193">193</xref>–<xref ref-type="bibr" rid="B195">195</xref>). Two of these studies used CASPR2 antibodies, cell surface IgG antibodies which have been implicated in encephalitis and a variety of peripheral nerve manifestations. Intriguingly, a study by Coutinho et al. found that NMDAR antibodies were more frequent in mothers of children with neurodevelopmental disorders, who themselves (i.e. the mothers) subsequently developed psychosis. This finding was not replicated in another cohort in which the mothers did not go on to develop psychosis, but clearly mandates attempts at replication (<xref ref-type="bibr" rid="B196">196</xref>). A recent animal study has shown that maternal-foetal transfer of recombinant NMDAR NR1 antibodies—at levels that did not affect the behavior of the pregnant mother—resulted in impaired neurodevelopmental reflexes, reduced anxiety, motor hyperactivity, and impaired sensorimotor gating, the latter two of which were regarded as psychosis-like phenotypes (<xref ref-type="bibr" rid="B197">197</xref>) (but see section “<italic>Experimental paradigms of maternal infection</italic>” for transdiagnostic relevance of these behaviors).</p>
</sec>
<sec id="s3_3">
<title>Influenza and Molecular Mimicry</title>
<p>The association between influenza infection and NMDAR autoantibody status may have structural molecular basis. The influenza A M2 channel and NMDAR share a ligand, the antiviral compound amantadine (<xref ref-type="bibr" rid="B198">198</xref>), suggesting putative structural homology which could form the basis for NMDAR autoimmunity occurring after infection. In molecular mimicry, there is sharing of sequences, such as linear amino acid sequences, by molecules from dissimilar genes or their protein products. In infection, if the virus shares cross-reactive epitopes for B or T cells with the host, the host immune cells can target both the infecting agent and the host itself, potentially inducing autoimmune disease (<xref ref-type="bibr" rid="B199">199</xref>). The processes involved include T<sub>c</sub> cells damaging self-tissue by lysis or T<sub>h</sub> cells releasing cytokines. Cytokines in turn activate macrophages or stimulate secretion of antibodies, and antibodies bind to cross-reactive epitopes on the surface of tissues, triggering further cytokine production by macrophages (<xref ref-type="bibr" rid="B200">200</xref>). Damaged tissues can also release new self-epitopes which activate autoantigen-reactive T and B cells, recognising those self-epitopes [epitope spreading; (<xref ref-type="bibr" rid="B201">201</xref>)].</p>
<p>There are multiple strands of evidence that influenza infection may have an aetiological role in systemic autoimmunity, including in Henoch-Schonlein purpura, type 1 diabetes mellitus and antiphospholipid syndrome [reviewed in (<xref ref-type="bibr" rid="B202">202</xref>)]. In one study, influenza vaccination induced autoimmunity (primarily antiphospholipid antibodies) in apparently healthy volunteers (<xref ref-type="bibr" rid="B203">203</xref>). H1N1 infection in rabbits has also been shown to induce brain-reactive antibodies, including to a 37kDa target also present in humans (<xref ref-type="bibr" rid="B204">204</xref>). Precedent for the role of influenza exposure initiating neurological disorder, potentially <italic>via</italic> molecular mimicry, exists for Guillain-Barre syndrome (<xref ref-type="bibr" rid="B205">205</xref>) and narcolepsy, in which hypocretin-producing neurons could be an autoimmune target due to molecular mimicry between H1N1 virus-derived antigen and a neuronal autoantigen in <italic>HLA-DQB1*06:02</italic> positive patients (<xref ref-type="bibr" rid="B206">206</xref>, <xref ref-type="bibr" rid="B207">207</xref>); see (<xref ref-type="bibr" rid="B208">208</xref>) for an example model of narcolepsy. This association is supported by epidemiological findings of an increased risk of narcolepsy in children following the H1N1 vaccination, Pandemrix (<xref ref-type="bibr" rid="B209">209</xref>, <xref ref-type="bibr" rid="B210">210</xref>), and by serological findings that antibodies to influenza nucleoprotein might cross-react with hypocretin receptor 2 in patients with Pandemrix vaccination [(<xref ref-type="bibr" rid="B211">211</xref>), although see (<xref ref-type="bibr" rid="B212">212</xref>–<xref ref-type="bibr" rid="B214">214</xref>)].</p>
<p>Further evidence for molecular mimicry as a bridging link between influenza infection, the adaptive immune response and neurodevelopmental risk for schizophrenia comes from gene sequence overlap between the H5N1 virus and genes abnormally regulated in schizophrenia (<xref ref-type="bibr" rid="B215">215</xref>). Furthermore, the H1N1 influenza antiviral protein hemagglutinin was found to share peptide structure with a variety of human axon guidance proteins; the majority of proteins identified as containing homologous sequences are involved in processes which, if disrupted, could lead to deviant neurodevelopmental trajectories. The observed peptide matches were conserved across influenza strains and frequently involved experimentally validated hemagglutinin epitopes (<xref ref-type="bibr" rid="B216">216</xref>). Finally, the NMDAR 2A subunit was found to share peptides with several pathogens, including the influenza A virus (<xref ref-type="bibr" rid="B217">217</xref>). The findings suggest that anti-pathogen immune responses to the influenza A virus may cross-react with multiple schizophrenia-related proteins. This reaction could potentially trigger processes which may ultimately lead to schizophrenia. Work from our group has confirmed the higher-than-expected overlap between the influenza proteome and schizophrenia-relevant proteins, additionally identifying hemagglutinin as contributing, amongst influenza proteins, the most extensive peptide sharing [Kepinska et al., <italic>in submission</italic>; see also (<xref ref-type="bibr" rid="B218">218</xref>)].</p>
</sec>
</sec>
<sec id="s4">
<title>Conclusion and Future Directions</title>
<p>Converging evidence demonstrates that infection with the influenza virus has a multiplicity of effects on prenatal and postnatal processes which, when disrupted, could result in increased risk of the development of schizophrenia or acute psychoses in adulthood. <xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref> outlines potential prenatal and postnatal pathogenic contributions. Nonetheless, it is important to emphasise that infection has been linked with increased risk of several psychiatric disorders (see <italic>Introduction</italic>). It is therefore not clear to what extent the mechanisms discussed in this review are schizophrenia-specific, or whether, as is highly likely, other factors may shape the clinical expression of disease.</p>
<fig id="f2" position="float">
<label>Figure 2</label>
<caption>
<p>Potential interactions between mechanisms related to influenza infection and development of schizophrenia or other psychotic disorders. Arrows indicate possible directions of interaction. Boxes represent different factors or changes which mediate processes possibly leading to the development of psychosis or schizophrenia.</p>
</caption>
<graphic xlink:href="fpsyt-11-00072-g002"></graphic>
</fig>
<p>Outstanding questions and possible future experimental approaches are summarized in <xref ref-type="boxed-text" rid="box1">
<bold>Box A</bold>
</xref>.<boxed-text id="box1" position="float"><caption><title>
<bold>Box A </bold>| Outstanding questions for future research.</title></caption><list list-type="simple"><list-item><p>- Do influenza MIA models, or models of adulthood influenza infection, demonstrate an antibody response to brain antigens including, for example, the NMDAR?</p></list-item><list-item><p>- Is there an epidemiological association between influenza vaccination (maternal, childhood or adulthood; seasonal or pandemic) with differential risk of subsequent development of psychotic disorder?</p></list-item><list-item><p>- Is antiviral use in pregnancy associated with a reduced risk of psychotic disorders in offspring?</p></list-item><list-item><p>- Is the acute response to influenza infection or vaccination in healthy individuals instructive for understanding the development of psychosis? Relevant approaches could include neuroimaging and behavioral testing following vaccination, similar to paradigms using LPS or typhoid vaccine administration (<xref ref-type="bibr" rid="B219">219</xref>–<xref ref-type="bibr" rid="B221">221</xref>).</p></list-item><list-item><p>- Will next generation viral metagenomic sequencing reveal differential presence of virus in biofluids from patients with psychotic disorders?</p></list-item><list-item><p>- Can an <italic>in silico</italic> approach be used to assess the plausibility of the molecular mimicry hypothesis, potentially assessing linear or structural overlap between viral proteome and schizophrenia-relevant proteins?</p></list-item></list></boxed-text> Future immunity-focused research on schizophrenia and influenza should further explore the relationship between infection and the innate and adaptive immune response in schizophrenia using animal models and large-scale serological studies in patients at different stages of disease. To date, MIA models typically include very little deep immunophenotyping, and discussion of the adaptive immune response in these models has been almost entirely lacking. Standardised and more sensitive testing technologies are required, including improved noninvasive methods to assess central neuroinflammation in humans and nonhuman animals (<xref ref-type="bibr" rid="B222">222</xref>, <xref ref-type="bibr" rid="B223">223</xref>).</p>
<p>Recent developments in stem cell technology suggest the possibility of using induced pluripotent stem-cell (iPSC) microglia-like cells [as per (<xref ref-type="bibr" rid="B149">149</xref>)] to assess how influenza infection affects the phenotype of these cells. Potentially, iPSC-derived cerebral organoids [so-called ‘mini brains’ (<xref ref-type="bibr" rid="B224">224</xref>)] could offer a window into the effects of influenza infection on relevant aspects of neurodevelopment.</p>
<p>While this paper reviews limited case studies and series indicating that in some instances influenza vaccination has been linked to CNS-directed autoimmunity, there is currently no evidence demonstrating a clear association between influenza vaccination and the development of schizophrenia or other psychotic disorders. The limited reported cases constitute a weight of evidence which is far weaker than the many epidemiological studies supporting the association between maternal influenza infection and schizophrenia. Influenza vaccination—both pandemic and seasonal—has saved and continues to save countless millions of lives worldwide, with an overwhelming evidence base supporting its efficacy. Within this context, influenza vaccination may nonetheless represent an as-yet underutilised opportunity for epidemiological and mechanistic explorations of potential influenza-psychosis associations. For example, healthy volunteers having the vaccination could be assessed using immunophenotyping, brain imaging, and behavioral measures to further characterize the acute response to influenza exposure [analogous to similar human studies of the acute response to LPS or typhoid vaccine administration (<xref ref-type="bibr" rid="B219">219</xref>–<xref ref-type="bibr" rid="B221">221</xref>)].</p>
<p>From the perspective of prevention of psychosis, consideration has been given to the potential use of antiviral medication in at-risk pregnant women. Although human studies are lacking, pilot studies in mice suggest that giving oseltamivir to pregnant mice can prevent some influenza-induced changes in the offspring (<xref ref-type="bibr" rid="B99">99</xref>). And while oseltamivir is regarded as having a favourable profile in pregnancy, there are no data on the long-term effects on neurodevelopment in human children.</p>
<p>Consideration has also been given to the potential role of influenza vaccines prior to, or during, pregnancy as a preventive measure to limit the prenatal teratogenic influence of viruses (<xref ref-type="bibr" rid="B225">225</xref>–<xref ref-type="bibr" rid="B227">227</xref>). The seasonal influenza vaccine has established efficacy in preventing maternal infection, as well as partially preventing the infant through passive immunity, and its administration remains best practice for protection of mother and child, with the World Health Organisation recognising pregnant women as a priority vulnerable group. In addition, educating pregnant women to contact their healthcare provide if they have a fever is recommended in order to expedite administration of antiviral medication and supportive care (<xref ref-type="bibr" rid="B228">228</xref>). Some authors consider the fact that influenza vaccination is not recommended in the first trimester in some countries as cause for concern, leaving women and the developing foetus vulnerable during a critical neurodevelopmental window (<xref ref-type="bibr" rid="B228">228</xref>). Epidemiologically, first trimester (or any other trimester) pandemic influenza vaccination does not appear to be associated with increased childhood morbidity (<xref ref-type="bibr" rid="B229">229</xref>). Although neurodevelopmental outcome data are largely lacking, some mouse models suggested that influenza vaccination early in pregnancy can indeed promote behavioral function and neurogenesis in the offspring, and confer protection from the effects of MIA with LPS (<xref ref-type="bibr" rid="B230">230</xref>, <xref ref-type="bibr" rid="B231">231</xref>). One note of caution has been raised by a cohort study of nearly 200,000 children in California which reported a small but statistically significantly increased risk of ASD following first trimester vaccination (<xref ref-type="bibr" rid="B232">232</xref>); unsurprisingly the report was controversial, with ensuing disagreement concerning interpretation of the findings and whether the correct statistical measures were used (<xref ref-type="bibr" rid="B233">233</xref>, <xref ref-type="bibr" rid="B234">234</xref>).</p>
<p>Given that the vast majority of children of mothers who experience an infection do not develop psychiatric disease, recent consideration has been given to maternal and foetal mechanisms of resilience to perinatal infection and inflammation: these include maternal nutritional status, the microbiome, and a variety of postnatal environmental factors (<xref ref-type="bibr" rid="B235">235</xref>). In terms of interventions within the MIA paradigm that have potential widespread relevance, dietary supplementation with omega-3 polyunsaturated fatty acids (PUFAs) may represent an attractive preventative strategy (<xref ref-type="bibr" rid="B236">236</xref>, <xref ref-type="bibr" rid="B237">237</xref>).</p>
<p>An increase in our understanding of neuro-immune interactions has enabled a fuller understanding of the mechanistic underpinnings of the neurodevelopmental hypothesis of schizophrenia and have contributed to a more nuanced picture of schizophrenia pathogenesis which can accommodate the influence of influenza infections after the perinatal period. Our understanding of both influenza and schizophrenia has changed immensely since the 1918-1919 pandemic. The development of next-generation genetic, immunological and bioinformatic technologies may bring a resolution of the centuries-old puzzle of the relationship between influenza and psychosis.</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>TP, RM, CI and AK developed the initial idea for the review. AK and TP wrote the first draft of the manuscript. AK, CI, AV, RY, RM and TP contributed to revision and editing of the manuscript.</p>
</sec>
<sec id="s6" sec-type="funding-information">
<title>Funding</title>
<p>TP was supported in a Clinical Research Training Fellowship by the Wellcome Trust (grant number: 105758/Z/14/Z) and in a clinical lectureship by the National Institute for Health Research (NIHR). AK is funded by the NIHR Maudsley Biomedical Research Centre at South London and Maudsley Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. AV acknowledges financial support from the Medical Research Council (New Investigator Research Grant (NIRG), MR/N025377/1). The work (at King’s College, London) was also supported by the Medical Research Council (MRC) Centre grant (MR/N026063/1). AV has received research funding from F. Hoffman La Roche Ltd and UBC Biopharma SPRL as part of a research programme on early life immune activation. The views expressed are those of the authors and not necessarily those of F. Hoffman La Roche or UCB Biopharma SPRL. These funders had no influence on the decision to publish this work.</p>
</sec>
<sec id="s7">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The handling editor declared a past collaboration with the authors TP and RY.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Sawa</surname><given-names>A</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name></person-group>
<article-title>Schizophrenia</article-title>. <source/>Lancet (<year>2016</year>) <volume>388</volume>(<issue>10039</issue>):<fpage>86</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(15)01121-6</pub-id>
<pub-id pub-id-type="pmid">26777917</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khandaker</surname><given-names>GM</given-names></name><name><surname>Cousins</surname><given-names>L</given-names></name><name><surname>Deakin</surname><given-names>J</given-names></name><name><surname>Lennox</surname><given-names>BR</given-names></name><name><surname>Yolken</surname><given-names>R</given-names></name><name><surname>Jones</surname><given-names>PB</given-names></name></person-group>
<article-title>Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment</article-title>. <source/>Lancet Psychiatry (<year>2015</year>) <volume>2</volume>(<issue>3</issue>):<page-range>258–70</page-range>. <pub-id pub-id-type="doi">10.1016/S2215-0366(14)00122-9</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corvin</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>DW</given-names></name></person-group>
<article-title>Genome-wide association studies: findings at the major histocompatibility complex locus in psychosis</article-title>. <source/>Biol Psychiatry (<year>2014</year>) <volume>75</volume>(<issue>4</issue>):<page-range>276–83</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.09.018</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Purcell</surname><given-names>SM</given-names></name><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Stone</surname><given-names>JL</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>O'Donovan</surname><given-names>MC</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><etal></etal></person-group>
<article-title>Common polygenic variation contributes to risk of schizophrenia and bipolar disorder</article-title>. <source/>Nature (<year>2009</year>) <volume>460</volume>(<issue>7256</issue>):<page-range>748–52</page-range>. <pub-id pub-id-type="doi">10.1038/nature08185</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McGuffin</surname><given-names>P</given-names></name><name><surname>Power</surname><given-names>RA</given-names></name></person-group>
<article-title>Schizophrenia as a human leukocyte antigen-associated disease revisited</article-title>. <source/>Am J Psychiatry (<year>2013</year>) <volume>170</volume>(<issue>8</issue>):<page-range>821–3</page-range>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2013.13030336</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<collab>Consortium, S.G.o.t.P.G</collab>. <article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>. <source/>Nature (<year>2014</year>) <volume>511</volume>(<issue>7510</issue>):<page-range>421–7</page-range>. <pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sekar</surname><given-names>A</given-names></name><name><surname>Bialas</surname><given-names>AR</given-names></name><name><surname>de Rivera</surname><given-names>H</given-names></name><name><surname>Davis</surname><given-names>A</given-names></name><name><surname>Hammond</surname><given-names>TR</given-names></name><name><surname>Kamitaki</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Schizophrenia risk from complex variation of complement component 4</article-title>. <source/>Nature (<year>2016</year>) <volume>530</volume>(<issue>7589</issue>):<page-range>177–83</page-range>. <pub-id pub-id-type="doi">10.1038/nature16549</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<collab>Schizophrenia Working Group of the Psychiatric Genomics, C</collab>. <article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>. <source/>Nature (<year>2014</year>) <volume>511</volume>(<issue>7510</issue>):<page-range>421–7</page-range>. <pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Mierlo</surname><given-names>HC</given-names></name><name><surname>Schot</surname><given-names>A</given-names></name><name><surname>Boks</surname><given-names>MPM</given-names></name><name><surname>de Witte</surname><given-names>,LD</given-names></name></person-group>
<article-title>The association between schizophrenia and the immune system: review of the evidence from unbiased 'omic-studies'</article-title>. <source/>Schizophr Res (<year>2019</year>) in press. <pub-id pub-id-type="doi">10.1016/j.schres.2019.05.028</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>Network and Pathway Analysis Subgroup of Psychiatric Genomics, C</collab></person-group>
<article-title>Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways</article-title>. <source/>Nat Neurosci (<year>2015</year>) <volume>18</volume>(<issue>2</issue>):<fpage>199</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3922</pub-id>
<pub-id pub-id-type="pmid">25599223</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pouget</surname><given-names>JG</given-names></name></person-group>
<article-title>The emerging immunogenetic architecture of schizophrenia</article-title>. <source/>Schizophr Bull (<year>2018</year>) <volume>44</volume>(<issue>5</issue>):<fpage>993</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1093/schbul/sby038</pub-id>
<pub-id pub-id-type="pmid">29701842</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pouget</surname><given-names>JG</given-names></name><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Mignot</surname><given-names>E</given-names></name><name><surname>Ollila</surname><given-names>HM</given-names></name><etal></etal></person-group>
<article-title>Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk</article-title>. <source/>Hum Mol Genet (<year>2019</year>) <volume>28</volume>(<issue>20</issue>):<page-range>3498–513</page-range>. <pub-id pub-id-type="doi">10.1093/hmg/ddz145</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benros</surname><given-names>ME</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><name><surname>Eaton</surname><given-names>WW</given-names></name></person-group>
<article-title>Autoimmune diseases and infections as risk factors for schizophrenia</article-title>. <source/>Ann N Y Acad Sci (<year>2012</year>) <volume>1262</volume>:<fpage>56</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06638.x</pub-id>
<pub-id pub-id-type="pmid">22823436</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benros</surname><given-names>ME</given-names></name><name><surname>Nielsen</surname><given-names>PR</given-names></name><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>Eaton</surname><given-names>WW</given-names></name><name><surname>Dalton</surname><given-names>SO</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name></person-group>
<article-title>Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study</article-title>. <source/>Am J Psychiatry (<year>2011</year>) <volume>168</volume>(<issue>12</issue>):<page-range>1303–10</page-range>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2011.11030516</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kohler</surname><given-names>O</given-names></name><name><surname>Petersen</surname><given-names>L</given-names></name><name><surname>Mors</surname><given-names>O</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><name><surname>Yolken</surname><given-names>RH</given-names></name><name><surname>Gasse</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study</article-title>. <source/>Acta Psychiatr Scand (<year>2017</year>) <volume>135</volume>(<issue>2</issue>):<fpage>97</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1111/acps.12671</pub-id>
<pub-id pub-id-type="pmid">27870529</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lydholm</surname><given-names>CN</given-names></name><name><surname>Kohler-Forsberg</surname><given-names>O</given-names></name><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>Yolken</surname><given-names>RH</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><name><surname>Petersen</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Parental infections before, during, and after pregnancy as risk factors for mental disorders in childhood and adolescence: a Nationwide danish study</article-title>. <source/>Biol Psychiatry (<year>2019</year>) <volume>85</volume>(<issue>4</issue>):<page-range>317–25</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2018.09.013</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yolken</surname><given-names>RH</given-names></name><name><surname>Torrey</surname><given-names>EF</given-names></name></person-group>
<article-title>Are some cases of psychosis caused by microbial agents? a review of the evidence</article-title>. <source/>Mol Psychiatry (<year>2008</year>) <volume>13</volume>(<issue>5</issue>):<page-range>470–9</page-range>. <pub-id pub-id-type="doi">10.1038/mp.2008.5</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khandaker</surname><given-names>GM</given-names></name><name><surname>Zimbron</surname><given-names>J</given-names></name><name><surname>Dalman</surname><given-names>C</given-names></name><name><surname>Lewis</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>PB</given-names></name></person-group>
<article-title>Childhood infection and adult schizophrenia: a meta-analysis of population-based studies</article-title>. <source/>Schizophr Res (<year>2012</year>) <volume>139</volume>(<issue>1-3</issue>):<page-range>161–8</page-range>. <pub-id pub-id-type="doi">10.1016/j.schres.2012.05.023</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khandaker</surname><given-names>GM</given-names></name><name><surname>Zimbron</surname><given-names>J</given-names></name><name><surname>Lewis</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>PB</given-names></name></person-group>
<article-title>Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies</article-title>. <source/>Psychol Med (<year>2013</year>) <volume>43</volume>(<issue>2</issue>):<page-range>239–57</page-range>. <pub-id pub-id-type="doi">10.1017/S0033291712000736</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Torrey</surname><given-names>EF</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Rawlings</surname><given-names>R</given-names></name><name><surname>Yolken</surname><given-names>RH</given-names></name></person-group>
<article-title>Seasonality of births in schizophrenia and bipolar disorder: a review of the literature</article-title>. <source/>Schizophr Res (<year>1997</year>) <volume>28</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/S0920-9964(97)00092-3</pub-id>
<pub-id pub-id-type="pmid">9428062</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barichello</surname><given-names>T</given-names></name><name><surname>Badawy</surname><given-names>M</given-names></name><name><surname>Pitcher</surname><given-names>MR</given-names></name><name><surname>Saigal</surname><given-names>P</given-names></name><name><surname>Generoso</surname><given-names>JS</given-names></name><name><surname>Goularte</surname><given-names>JA</given-names></name><etal></etal></person-group>
<article-title>Exposure to perinatal infections and bipolar disorder: a systematic review</article-title>. <source/>Curr Mol Med (<year>2016</year>) <volume>16</volume>(<issue>2</issue>):<page-range>106–18</page-range>. <pub-id pub-id-type="doi">10.2174/1566524016666160126143741</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marangoni</surname><given-names>C</given-names></name><name><surname>Hernandez</surname><given-names>M</given-names></name><name><surname>Faedda</surname><given-names>GL</given-names></name></person-group>
<article-title>The role of environmental exposures as risk factors for bipolar disorder: a systematic review of longitudinal studies</article-title>. <source/>J Affect Disord (<year>2016</year>) <volume>193</volume>:<page-range>165–74</page-range>. <pub-id pub-id-type="doi">10.1016/j.jad.2015.12.055</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>AS</given-names></name></person-group>
<article-title>The Kraepelinian dichotomy from the perspective of prenatal infectious and immunologic insults</article-title>. <source/>Schizophr Bull (<year>2015</year>) <volume>41</volume>(<issue>4</issue>):<page-range>786–91</page-range>. <pub-id pub-id-type="doi">10.1093/schbul/sbv063</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canetta</surname><given-names>SE</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Co</surname><given-names>MD</given-names></name><name><surname>Ennis</surname><given-names>FA</given-names></name><name><surname>Cruz</surname><given-names>J</given-names></name><name><surname>Terajima</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring</article-title>. <source/>Am J Psychiatry (<year>2014</year>) <volume>171</volume>(<issue>5</issue>):<page-range>557–63</page-range>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2013.13070943</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>AS</given-names></name></person-group>
<article-title>Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism</article-title>. <source/>Dev Neurobiol (<year>2012</year>) <volume>72</volume>(<issue>10</issue>):<page-range>1272–6</page-range>. <pub-id pub-id-type="doi">10.1002/dneu.22024</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kohler-Forsberg</surname><given-names>O</given-names></name><name><surname>Petersen</surname><given-names>L</given-names></name><name><surname>Gasse</surname><given-names>C</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><name><surname>Dalsgaard</surname><given-names>S</given-names></name><name><surname>Yolken</surname><given-names>RH</given-names></name><etal></etal></person-group>
<article-title>A nationwide study in Denmark of the association between treated infections and the subsequent risk of treated mental disorders in children and adolescents</article-title>. <source/>JAMA Psychiatry (<year>2019</year>) <volume>76</volume>(<issue>3</issue>):<page-range>271–9</page-range>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2018.3428</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benros</surname><given-names>ME</given-names></name><name><surname>Waltoft</surname><given-names>BL</given-names></name><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>Ostergaard</surname><given-names>SD</given-names></name><name><surname>Eaton</surname><given-names>WW</given-names></name><name><surname>Krogh</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study</article-title>. <source/>JAMA Psychiatry (<year>2013</year>) <volume>70</volume>(<issue>8</issue>):<page-range>812–20</page-range>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.1111</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Honigsbaum</surname><given-names>M</given-names></name></person-group>
<source/>A History of the Great Influenza Pandemics: Death, Panic and Hysteria. <publisher-loc>London</publisher-loc>: <publisher-name>I.B. Tauris</publisher-name> (<year>2014</year>) p. <page-range>1830–920</page-range>.</mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Honigsbaum</surname><given-names>M</given-names></name></person-group>
<article-title>"An inexpressible dread": psychoses of influenza at fin-de-siecle</article-title>. <source/>Lancet (<year>2013</year>) <volume>381</volume>(<issue>9871</issue>):<page-range>988–9</page-range>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60701-1</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menninger</surname><given-names>KA</given-names></name></person-group>
<article-title>Psychoses associated with influenza: i. general data: statistical analysis</article-title>. <source/>JAMA (<year>1919</year>) <volume>72</volume>(<issue>4</issue>):<page-range>235–41</page-range>. <pub-id pub-id-type="doi">10.1001/jama.1919.02610040001001</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menninger</surname><given-names>KA</given-names></name></person-group>
<article-title>Influenza and schizophrenia. An analysis of post-influenzal "dementia precox," as of 1918, and five years later further studies of the psychiatric aspects of influenza 1926</article-title>. <source/>Am J Psychiatry (<year>1994</year>) <volume>151</volume>(<issue>6 Suppl</issue>):<page-range>182–7</page-range>. <pub-id pub-id-type="doi">10.1176/ajp.151.6.182</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>von Economo</surname><given-names>C</given-names></name></person-group>
<source/>Encephalitis lethargica: its sequelae and treatment. <publisher-loc>Oxford, England</publisher-loc>: <publisher-name>Oxford Univ. Press</publisher-name> (<year>1931</year>). xvi, 200.</mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hilleman</surname><given-names>MR</given-names></name></person-group>
<article-title>Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control</article-title>. <source/>Vaccine (<year>2002</year>) <volume>20</volume>(<issue>25-26</issue>):<page-range>3068–87</page-range>. <pub-id pub-id-type="doi">10.1016/S0264-410X(02)00254-2</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kraepelin</surname><given-names>E</given-names></name></person-group>
<article-title>Ueber psychosen nach influenza</article-title>. <source/>Dtsch Med Wochenschr (<year>1890</year>) <volume>16</volume>(<issue>11</issue>):<page-range>209–12</page-range>. <pub-id pub-id-type="doi">10.1055/s-0029-1207083</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menninger</surname><given-names>KA</given-names></name></person-group>
<article-title>Psychoses associated with influenza - I - general data statistical analysis</article-title>. <source/>J Am Med Assoc (<year>1919</year>) <volume>72</volume>:<page-range>235–41</page-range>. <pub-id pub-id-type="doi">10.1001/jama.1919.02610040001001</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bental</surname><given-names>E</given-names></name></person-group>
<article-title>Acute psychoses due to encephalitis following Asian influenza</article-title>. <source/>Lancet (<year>1958</year>) <volume>2</volume>(<issue>Jul5</issue>):<fpage>18</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(58)90005-9</pub-id>
<pub-id pub-id-type="pmid">13564748</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McGrath</surname><given-names>JJ</given-names></name><name><surname>Pemberton</surname><given-names>MR</given-names></name><name><surname>Welham</surname><given-names>JL</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name></person-group>
<article-title>Schizophrenia and the influenza epidemics of 1954, 1957 and 1959 - a southern-hemisphere study</article-title>. <source/>Schizophr Res (<year>1994</year>) <volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/0920-9964(94)90002-7</pub-id>
<pub-id pub-id-type="pmid">7893616</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mednick</surname><given-names>SA</given-names></name><name><surname>Machon</surname><given-names>RA</given-names></name><name><surname>Huttunen</surname><given-names>MO</given-names></name><name><surname>Bonett</surname><given-names>D</given-names></name></person-group>
<article-title>Adult schizophrenia following prenatal exposure to an influenza epidemic</article-title>. <source/>Arch Gen Psychiatry (<year>1988</year>) <volume>45</volume>(<issue>2</issue>):<page-range>189–92</page-range>. <pub-id pub-id-type="doi">10.1001/archpsyc.1988.01800260109013</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kunugi</surname><given-names>H</given-names></name><name><surname>Nanko</surname><given-names>S</given-names></name><name><surname>Takei</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>N</given-names></name><name><surname>Kazamatsuri</surname><given-names>H</given-names></name></person-group>
<article-title>Schizophrenia following in utero exposure to the 1957 influenza epidemics in Japan</article-title>. <source/>Am J Psychiatry (<year>1995</year>) <volume>152</volume>(<issue>3</issue>):<page-range>450–2</page-range>. <pub-id pub-id-type="doi">10.1176/ajp.152.3.450</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adams</surname><given-names>W</given-names></name><name><surname>Kendell</surname><given-names>RE</given-names></name><name><surname>Hare</surname><given-names>EH</given-names></name><name><surname>Munk-Jorgensen</surname><given-names>P</given-names></name></person-group>
<article-title>Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. an analysis of Scottish, English, and Danish data</article-title>. <source/>Br J Psychiatry (<year>1993</year>) <volume>163</volume>:<page-range>522–34</page-range>. <pub-id pub-id-type="doi">10.1192/bjp.163.4.522</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O'Callaghan</surname><given-names>E</given-names></name><name><surname>Sham</surname><given-names>P</given-names></name><name><surname>Takei</surname><given-names>N</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name><name><surname>Glover</surname><given-names>G</given-names></name></person-group>
<article-title>Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic</article-title>. <source/>Lancet (<year>1991</year>) <volume>337</volume>(<issue>8752</issue>):<page-range>1248–50</page-range>. <pub-id pub-id-type="doi">10.1016/0140-6736(91)92919-S</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Still</surname><given-names>RM</given-names></name></person-group>
<article-title>Psychosis following Asian influenza in Barbados</article-title>. <source/>Lancet (<year>1958</year>) <volume>2</volume>(<issue>7036</issue>):<page-range>20–1</page-range>. <pub-id pub-id-type="doi">10.1016/S0140-6736(58)90006-0</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Selten</surname><given-names>JP</given-names></name><name><surname>Frissen</surname><given-names>A</given-names></name><name><surname>Lensvelt-Mulders</surname><given-names>G</given-names></name><name><surname>Morgan</surname><given-names>VA</given-names></name></person-group>
<article-title>Schizophrenia and 1957 pandemic of influenza: meta-analysis</article-title>. <source/>Schizophr Bull (<year>2010</year>) <volume>36</volume>(<issue>2</issue>):<page-range>219–28</page-range>. <pub-id pub-id-type="doi">10.1093/schbul/sbp147</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khandaker</surname><given-names>G</given-names></name><name><surname>Zurynski</surname><given-names>Y</given-names></name><name><surname>Buttery</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>H</given-names></name><name><surname>Richmond</surname><given-names>PC</given-names></name><name><surname>Dale</surname><given-names>RC</given-names></name><etal></etal></person-group>
<article-title>Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals</article-title>. <source/>Neurology (<year>2012</year>) <volume>79</volume>(<issue>14</issue>):<page-range>1474–81</page-range>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e31826d5ea7</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>CH</given-names></name><name><surname>Chang</surname><given-names>YC</given-names></name><name><surname>Tzang</surname><given-names>RF</given-names></name></person-group>
<article-title>Childhood psychosis after H1N1 influenza</article-title>. <source/>J Neuropsychiatry Clin Neurosci (<year>2015</year>) <volume>27</volume>(<issue>1</issue>):<page-range>e87–9</page-range>. <pub-id pub-id-type="doi">10.1176/appi.neuropsych.14010012</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>Welham</surname><given-names>J</given-names></name><name><surname>Chant</surname><given-names>D</given-names></name><name><surname>Torrey</surname><given-names>EF</given-names></name><name><surname>McGrath</surname><given-names>J</given-names></name></person-group>
<article-title>A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia</article-title>. <source/>Schizophr Bull (<year>2003</year>) <volume>29</volume>(<issue>3</issue>):<page-range>587–93</page-range>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.schbul.a007030</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>AS</given-names></name><name><surname>Derkits</surname><given-names>EJ</given-names></name></person-group>
<article-title>Prenatal infection and schizophrenia: a review of epidemiologic and translational studies</article-title>. <source/>Am J Psychiatry (<year>2010</year>) <volume>167</volume>(<issue>3</issue>):<page-range>261–80</page-range>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2009.09030361</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Erlenmeyer-Kimling</surname><given-names>L</given-names></name><name><surname>Folnegovic</surname><given-names>Z</given-names></name><name><surname>Hrabak-Zerjavic</surname><given-names>V</given-names></name><name><surname>Borcic</surname><given-names>B</given-names></name><name><surname>Folnegovic-Smalc</surname><given-names>V</given-names></name><name><surname>Susser</surname><given-names>E</given-names></name></person-group>
<article-title>Schizophrenia and prenatal exposure to the 1957 A2 influenza epidemic in Croatia</article-title>. <source/>Am J Psychiatry (<year>1994</year>) <volume>151</volume>(<issue>10</issue>):<page-range>1496–8</page-range>. <pub-id pub-id-type="doi">10.1176/ajp.151.10.1496</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Susser</surname><given-names>E</given-names></name><name><surname>Lin</surname><given-names>SP</given-names></name><name><surname>Brown</surname><given-names>AS</given-names></name><name><surname>Lumey</surname><given-names>LH</given-names></name><name><surname>Erlenmeyer-Kimling</surname><given-names>L</given-names></name></person-group>
<article-title>No relation between risk of schizophrenia and prenatal exposure to influenza in Holland</article-title>. <source/>Am J Psychiatry (<year>1994</year>) <volume>151</volume>(<issue>6</issue>):<page-range>922–4</page-range>. <pub-id pub-id-type="doi">10.1176/ajp.151.6.922</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>AS</given-names></name><name><surname>Begg</surname><given-names>MD</given-names></name><name><surname>Gravenstein</surname><given-names>S</given-names></name><name><surname>Schaefer</surname><given-names>CA</given-names></name><name><surname>Wyatt</surname><given-names>RJ</given-names></name><name><surname>Bresnahan</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Serologic evidence of prenatal influenza in the etiology of schizophrenia</article-title>. <source/>Arch Gen Psychiatry (<year>2004</year>) <volume>61</volume>(<issue>8</issue>):<page-range>774–80</page-range>. <pub-id pub-id-type="doi">10.1001/archpsyc.61.8.774</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Selten</surname><given-names>JP</given-names></name><name><surname>Termorshuizen</surname><given-names>F</given-names></name></person-group>
<article-title>The serological evidence for maternal influenza as risk factor for psychosis in offspring is insufficient: critical review and meta-analysis</article-title>. <source/>Schizophr Res (<year>2017</year>) <volume>183</volume>:<fpage>2</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2016.11.006</pub-id>
<pub-id pub-id-type="pmid">27856157</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>AS</given-names></name><name><surname>Meyer</surname><given-names>U</given-names></name></person-group>
<article-title>Comment on: “The serological evidence for maternal influenza as risk factor for psychosis in offspring is insufficient: critical review and meta-analysis”</article-title>. <source/>Schizophr Res (<year>2017</year>) <volume>189</volume>:<page-range>223–4</page-range>. <pub-id pub-id-type="doi">10.1016/j.schres.2017.02.023</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wright</surname><given-names>P</given-names></name><name><surname>Takei</surname><given-names>N</given-names></name><name><surname>Rifkin</surname><given-names>L</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name></person-group>
<article-title>Maternal influenza, obstetric complications, and schizophrenia</article-title>. <source/>Am J Psychiatry (<year>1995</year>) <volume>152</volume>(<issue>12</issue>):<page-range>1714–20</page-range>. <pub-id pub-id-type="doi">10.1176/ajp.152.12.1714</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hultman</surname><given-names>CM</given-names></name><name><surname>Sparen</surname><given-names>P</given-names></name><name><surname>Takei</surname><given-names>N</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name><name><surname>Cnattingius</surname><given-names>S</given-names></name></person-group>
<article-title>Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study</article-title>. <source/>BMJ (<year>1999</year>) <volume>318</volume>(<issue>7181</issue>):<page-range>421–6</page-range>. <pub-id pub-id-type="doi">10.1136/bmj.318.7181.421</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dreier</surname><given-names>JW</given-names></name><name><surname>Berg-Beckhoff</surname><given-names>G</given-names></name><name><surname>Andersen</surname><given-names>AMN</given-names></name><name><surname>Susser</surname><given-names>E</given-names></name><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>Strandberg-Larsen</surname><given-names>K</given-names></name></person-group>
<article-title>Fever and infections during pregnancy and psychosis-like experiences in the offspring at age 11. A prospective study within the Danish National Birth Cohort</article-title>. <source/>Psychol Med (<year>2018</year>) <volume>48</volume>(<issue>3</issue>):<page-range>426–36</page-range>. <pub-id pub-id-type="doi">10.1017/S0033291717001805</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murray</surname><given-names>RM</given-names></name><name><surname>Lewis</surname><given-names>SW</given-names></name></person-group>
<article-title>Is schizophrenia a neurodevelopmental disorder?</article-title>
<source/>Br Med J (Clin Res ed.) (<year>1987</year>) <volume>295</volume>(<issue>6600</issue>):<page-range>681–2</page-range>. <pub-id pub-id-type="doi">10.1136/bmj.295.6600.681</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group>
<article-title>Implications of normal brain development for the pathogenesis of schizophrenia</article-title>. <source/>Arch Gen Psychiatry (<year>1987</year>) <volume>44</volume>(<issue>7</issue>):<page-range>660–9</page-range>. <pub-id pub-id-type="doi">10.1001/archpsyc.1987.01800190080012</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name></person-group>
<article-title>The Neurodevelopmental hypothesis of schizophrenia, revisited</article-title>. <source/>Schizophr Bull (<year>2009</year>) <volume>35</volume>(<issue>3</issue>):<page-range>528–48</page-range>. <pub-id pub-id-type="doi">10.1093/schbul/sbn187</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rapoport</surname><given-names>JL</given-names></name><name><surname>Giedd</surname><given-names>JN</given-names></name><name><surname>Gogtay</surname><given-names>N</given-names></name></person-group>
<article-title>Neurodevelopmental model of schizophrenia: update 2012</article-title>. <source/>Mol Psychiatry (<year>2012</year>) <volume>17</volume>(<issue>12</issue>):<page-range>1228–38</page-range>. <pub-id pub-id-type="doi">10.1038/mp.2012.23</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Howes</surname><given-names>OD</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name></person-group>
<article-title>Schizophrenia: an integrated sociodevelopmental-cognitive model</article-title>. <source/>Lancet (<year>2014</year>) <volume>383</volume>(<issue>9929</issue>):<page-range>1677–87</page-range>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)62036-X</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Folsom</surname><given-names>DP</given-names></name><name><surname>Lebowitz</surname><given-names>BD</given-names></name><name><surname>Lindamer</surname><given-names>LA</given-names></name><name><surname>Palmer</surname><given-names>BW</given-names></name><name><surname>Patterson</surname><given-names>TL</given-names></name><name><surname>Jeste</surname><given-names>DV</given-names></name></person-group>
<article-title>Schizophrenia in late life: emerging issues</article-title>. <source/>Dialog Clin Neurosci (<year>2006</year>) <volume>8</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>52</lpage>.</mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kochunov</surname><given-names>P</given-names></name><name><surname>Hong</surname><given-names>LE</given-names></name></person-group>
<article-title>Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage</article-title>. <source/>Schizophr Bull (<year>2014</year>) <volume>40</volume>(<issue>4</issue>):<page-range>721–8</page-range>. <pub-id pub-id-type="doi">10.1093/schbul/sbu070</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keshavan</surname><given-names>MS</given-names></name></person-group>
<article-title>Development, disease and degeneration in schizophrenia: a unitary pathophysiological model</article-title>. <source/>J Psychiatr Res (<year>1999</year>) <volume>33</volume>(<issue>6</issue>):<page-range>513–21</page-range>. <pub-id pub-id-type="doi">10.1016/S0022-3956(99)00033-3</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davis</surname><given-names>J</given-names></name><name><surname>Eyre</surname><given-names>H</given-names></name><name><surname>Jacka</surname><given-names>FN</given-names></name><name><surname>Dodd</surname><given-names>S</given-names></name><name><surname>Dean</surname><given-names>O</given-names></name><name><surname>McEwen</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis</article-title>. <source/>Neurosci Biobehav Rev (<year>2016</year>) <volume>65</volume>:<page-range>185–94</page-range>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.03.017</pub-id>
</mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blomström</surname><given-names>Å.</given-names></name><name><surname>Karlsson</surname><given-names>H</given-names></name><name><surname>Gardner</surname><given-names>R</given-names></name><name><surname>Jorgensen</surname><given-names>L</given-names></name><name><surname>Magnusson</surname><given-names>C</given-names></name><name><surname>Dalman</surname><given-names>C</given-names></name></person-group>
<article-title>Associations between maternal infection during pregnancy, childhood infections, and the risk of subsequent psychotic disorder–a Swedish cohort study of nearly 2 million individuals</article-title>. <source/>Schizophr Bull (<year>2016</year>) <volume>42</volume>(<issue>1</issue>):<page-range>125–33</page-range>. <pub-id pub-id-type="doi">10.1093/schbul/sbv112</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rubicz</surname><given-names>R</given-names></name><name><surname>Leach</surname><given-names>CT</given-names></name><name><surname>Kraig</surname><given-names>E</given-names></name><name><surname>Dhurandhar</surname><given-names>NV</given-names></name><name><surname>Duggirala</surname><given-names>R</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Genetic factors influence serological measures of common infections</article-title>. <source/>Hum Hered (<year>2011</year>) <volume>72</volume>(<issue>2</issue>):<page-range>133–41</page-range>. <pub-id pub-id-type="doi">10.1159/000331220</pub-id>
</mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rubicz</surname><given-names>R</given-names></name><name><surname>Yolken</surname><given-names>R</given-names></name><name><surname>Drigalenko</surname><given-names>E</given-names></name><name><surname>Carless</surname><given-names>MA</given-names></name><name><surname>Dyer</surname><given-names>TD</given-names></name><name><surname>Kent</surname><given-names>J</given-names><suffix>Jr.</suffix></name><etal></etal></person-group>
<article-title>Genome-wide genetic investigation of serological measures of common infections</article-title>. <source/>Eur J Hum Genet (<year>2015</year>) <volume>23</volume>(<issue>11</issue>):<page-range>1544–8</page-range>. <pub-id pub-id-type="doi">10.1038/ejhg.2015.24</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hammer</surname><given-names>C</given-names></name><name><surname>Begemann</surname><given-names>M</given-names></name><name><surname>McLaren</surname><given-names>PJ</given-names></name><name><surname>Bartha</surname><given-names>I</given-names></name><name><surname>Michel</surname><given-names>A</given-names></name><name><surname>Klose</surname><given-names>B</given-names></name><etal></etal></person-group>
<article-title>Amino acid variation in HLA Class II proteins is a major determinant of humoral response to common viruses</article-title>. <source/>Am J Hum Genet (<year>2015</year>) <volume>97</volume>(<issue>5</issue>):<page-range>738–43</page-range>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.09.008</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Avramopoulos</surname><given-names>D</given-names></name><name><surname>Pearce</surname><given-names>BD</given-names></name><name><surname>McGrath</surname><given-names>J</given-names></name><name><surname>Wolyniec</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Eckart</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation</article-title>. <source/>PloS One (<year>2015</year>) <volume>10</volume>(<issue>3</issue>):<fpage>e0116696</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0116696</pub-id>
<pub-id pub-id-type="pmid">25781172</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>AW</given-names></name><name><surname>Avramopoulos</surname><given-names>D</given-names></name><name><surname>Lori</surname><given-names>A</given-names></name><name><surname>Mulle</surname><given-names>J</given-names></name><name><surname>Conneely</surname><given-names>K</given-names></name><name><surname>Powers</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Genome-wide association study in two populations to determine genetic variants associated with Toxoplasma gondii infection and relationship to schizophrenia risk</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry (<year>2019</year>) <volume>92</volume>:<page-range>133–47</page-range>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2018.12.019</pub-id>
</mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grove</surname><given-names>J</given-names></name><name><surname>Borglum</surname><given-names>AD</given-names></name><name><surname>Pearce</surname><given-names>BD</given-names></name></person-group>
<article-title>GWAS, cytomegalovirus infection, and schizophrenia</article-title>. <source/>Curr Behav Neurosci Rep (<year>2014</year>) <volume>1</volume>(<issue>4</issue>):<page-range>215–23</page-range>. <pub-id pub-id-type="doi">10.1007/s40473-014-0022-1</pub-id>
</mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leppert</surname><given-names>B</given-names></name><name><surname>Havdahl</surname><given-names>A</given-names></name><name><surname>Riglin</surname><given-names>L</given-names></name><name><surname>Jones</surname><given-names>HJ</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Association of maternal neurodevelopmental risk alleles with early-life exposures</article-title>. <source/>JAMA Psychiatry (<year>2019</year>) <volume>76</volume>(<issue>8</issue>):<page-range>834–42</page-range>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2019.0774</pub-id>
</mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benros</surname><given-names>ME</given-names></name><name><surname>Trabjerg</surname><given-names>BB</given-names></name><name><surname>Meier</surname><given-names>S</given-names></name><name><surname>Mattheisen</surname><given-names>M</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><name><surname>Mors</surname><given-names>O</given-names></name><etal></etal></person-group>
<article-title>Influence of Polygenic risk scores on the association between infections and schizophrenia</article-title>. <source/>Biol Psychiatry (<year>2016</year>) <volume>80</volume>(<issue>8</issue>):<page-range>609–16</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2016.04.008</pub-id>
</mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Shaw</surname><given-names>M</given-names></name><name><surname>Palese</surname><given-names>P</given-names></name></person-group>
<article-title>Orthomyxoviridae</article-title>. In: <person-group person-group-type="editor"><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name></person-group>, editors. <source/>Fields virology. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott Williams and Wilkins</publisher-name> (<year>2013</year>). p. <page-range>1151–84</page-range>.</mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Treanor</surname><given-names>J</given-names></name></person-group>
<article-title>Influenza (including avian influenza and swine influenza)</article-title>. In: <person-group person-group-type="editor"><name><surname>D.R. Bennett</surname><given-names>JE</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name></person-group>, editors. <source/>Mandell, Douglas, and Bennett"s Principles and Practice of Infectious Diseases, <edition>8th ed</edition>
<publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Elsevier Saunders</publisher-name> (<year>2015</year>). p. <page-range>2000–24</page-range>.</mixed-citation>
</ref>
<ref id="B76">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sadasivan</surname><given-names>S</given-names></name><name><surname>Zanin</surname><given-names>M</given-names></name><name><surname>O'Brien</surname><given-names>K</given-names></name><name><surname>Schultz-Cherry</surname><given-names>S</given-names></name><name><surname>Smeyne</surname><given-names>RJ</given-names></name></person-group>
<article-title>Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus</article-title>. <source/>PloS One (<year>2015</year>) <volume>10</volume>(<issue>4</issue>):<fpage>e0124047</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0124047</pub-id>
<pub-id pub-id-type="pmid">25861024</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xin</surname><given-names>G</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Apoptosis and proinflammatory cytokine responses of primary mouse microglia and astrocytes induced by human H1N1 and avian H5N1 influenza viruses</article-title>. <source/>Cell Mol Immunol (<year>2008</year>) <volume>5</volume>(<issue>2</issue>):<page-range>113–20</page-range>. <pub-id pub-id-type="doi">10.1038/cmi.2008.14</pub-id>
</mixed-citation>
</ref>
<ref id="B78">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jang</surname><given-names>HM</given-names></name><name><surname>Boltz</surname><given-names>D</given-names></name><name><surname>Sturm-Ramirez</surname><given-names>K</given-names></name><name><surname>Shepherd</surname><given-names>KR</given-names></name><name><surname>Jiao</surname><given-names>Y</given-names></name><name><surname>Webster</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration</article-title>. <source/>Proc Natl Acad Sci United States America (<year>2009</year>) <volume>106</volume>(<issue>33</issue>):<page-range>14063–8</page-range>. <pub-id pub-id-type="doi">10.1073/pnas.0900096106</pub-id>
</mixed-citation>
</ref>
<ref id="B79">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kash</surname><given-names>JC</given-names></name><name><surname>Taubenberger</surname><given-names>JK</given-names></name></person-group>
<article-title>The role of viral, host, and secondary bacterial factors in influenza pathogenesis</article-title>. <source/>Am J Pathol (<year>2015</year>) <volume>185</volume>(<issue>6</issue>):<page-range>1528–36</page-range>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2014.08.030</pub-id>
</mixed-citation>
</ref>
<ref id="B80">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kreijtz</surname><given-names>JH</given-names></name><name><surname>Fouchier</surname><given-names>RA</given-names></name><name><surname>Rimmelzwaan</surname><given-names>GF</given-names></name></person-group>
<article-title>Immune responses to influenza virus infection</article-title>. <source/>Virus Res (<year>2011</year>) <volume>162</volume>(<issue>1-2</issue>):<fpage>19</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2011.09.022</pub-id>
<pub-id pub-id-type="pmid">21963677</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carragher</surname><given-names>DM</given-names></name><name><surname>Kaminski</surname><given-names>DA</given-names></name><name><surname>Moquin</surname><given-names>A</given-names></name><name><surname>Hartson</surname><given-names>L</given-names></name><name><surname>Randall</surname><given-names>TD</given-names></name></person-group>
<article-title>A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus</article-title>. <source/>J Immunol (<year>2008</year>) <volume>181</volume>(<issue>6</issue>):<page-range>4168–76</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.6.4168</pub-id>
</mixed-citation>
</ref>
<ref id="B82">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aronsson</surname><given-names>F</given-names></name><name><surname>Lannebo</surname><given-names>C</given-names></name><name><surname>Paucar</surname><given-names>M</given-names></name><name><surname>Brask</surname><given-names>J</given-names></name><name><surname>Kristensson</surname><given-names>K</given-names></name><name><surname>Karlsson</surname><given-names>H</given-names></name></person-group>
<article-title>Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy</article-title>. <source/>J Neurovirol (<year>2002</year>) <volume>8</volume>(<issue>4</issue>):<page-range>353–7</page-range>. <pub-id pub-id-type="doi">10.1080/13550280290100480</pub-id>
</mixed-citation>
</ref>
<ref id="B83">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>AS</given-names></name><name><surname>Meyer</surname><given-names>U</given-names></name></person-group>
<article-title>Maternal immune activation and neuropsychiatric illness: a translational research perspective</article-title>. <source/>Am J Psychiatry (<year>2018</year>) <volume>175</volume>(<issue>11</issue>):<page-range>1073–83</page-range>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2018.17121311</pub-id>
</mixed-citation>
</ref>
<ref id="B84">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Estes</surname><given-names>ML</given-names></name><name><surname>McAllister</surname><given-names>AK</given-names></name></person-group>
<article-title>Maternal immune activation: implications for neuropsychiatric disorders</article-title>. <source/>Science (<year>2016</year>) <volume>353</volume>(<issue>6301</issue>):<page-range>772–7</page-range>. <pub-id pub-id-type="doi">10.1126/science.aag3194</pub-id>
</mixed-citation>
</ref>
<ref id="B85">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>U</given-names></name></person-group>
<article-title>Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems</article-title>. <source/>Biol Psychiatry (<year>2014</year>) <volume>75</volume>(<issue>4</issue>):<page-range>307–15</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.07.011</pub-id>
</mixed-citation>
</ref>
<ref id="B86">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harvey</surname><given-names>L</given-names></name><name><surname>Boksa</surname><given-names>P</given-names></name></person-group>
<article-title>Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders</article-title>. <source/>Dev Neurobiol (<year>2012</year>) <volume>72</volume>(<issue>10</issue>):<page-range>1335–48</page-range>. <pub-id pub-id-type="doi">10.1002/dneu.22043</pub-id>
</mixed-citation>
</ref>
<ref id="B87">
<label>87</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giovanoli</surname><given-names>S</given-names></name><name><surname>Engler</surname><given-names>H</given-names></name><name><surname>Engler</surname><given-names>A</given-names></name><name><surname>Richetto</surname><given-names>J</given-names></name><name><surname>Voget</surname><given-names>M</given-names></name><name><surname>Willi</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice</article-title>. <source/>Science (<year>2013</year>) <volume>339</volume>(<issue>6123</issue>):<page-range>1095–9</page-range>. <pub-id pub-id-type="doi">10.1126/science.1228261</pub-id>
</mixed-citation>
</ref>
<ref id="B88">
<label>88</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arad</surname><given-names>M</given-names></name><name><surname>Piontkewitz</surname><given-names>Y</given-names></name><name><surname>Albelda</surname><given-names>N</given-names></name><name><surname>Shaashua</surname><given-names>L</given-names></name><name><surname>Weiner</surname><given-names>I</given-names></name></person-group>
<article-title>Immune activation in lactating dams alters sucklings' brain cytokines and produces non-overlapping behavioral deficits in adult female and male offspring: a novel neurodevelopmental model of sex-specific psychopathology</article-title>. <source/>Brain Behav Immun (<year>2017</year>) <volume>63</volume>:<fpage>35</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2017.01.015</pub-id>
<pub-id pub-id-type="pmid">28189716</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levine</surname><given-names>J</given-names></name><name><surname>Buchman</surname><given-names>CA</given-names></name><name><surname>Fregien</surname><given-names>N</given-names></name></person-group>
<article-title>Influenza A virus infection of human Schwann cells in vitro</article-title>. <source/>Acta Oto-Laryngologica (<year>2003</year>) <volume>123</volume>(<issue>1</issue>):<page-range>41–5</page-range>. <pub-id pub-id-type="doi">10.1080/0036554021000028092</pub-id>
</mixed-citation>
</ref>
<ref id="B90">
<label>90</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakai</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Mizuguchi</surname><given-names>M</given-names></name><name><surname>Ozawa</surname><given-names>H</given-names></name><name><surname>Okazaki</surname><given-names>E</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Apoptosis and microglial activation in influenza encephalopathy</article-title>. <source/>Acta Neuropathol (<year>2003</year>) <volume>105</volume>(<issue>3</issue>):<page-range>233–9</page-range>. <pub-id pub-id-type="doi">10.1007/s00401-002-0605-x</pub-id>
</mixed-citation>
</ref>
<ref id="B91">
<label>91</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smolders</surname><given-names>S</given-names></name><name><surname>Notter</surname><given-names>T</given-names></name><name><surname>Smolders</surname><given-names>SMT</given-names></name><name><surname>Rigo</surname><given-names>JM</given-names></name><name><surname>Brone</surname><given-names>B</given-names></name></person-group>
<article-title>Controversies and prospects about microglia in maternal immune activation models for neurodevelopmental disorders</article-title>. <source/>Brain Behav Immun (<year>2018</year>) <volume>73</volume>:<fpage>51</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2018.06.001</pub-id>
<pub-id pub-id-type="pmid">29870753</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brask</surname><given-names>J</given-names></name><name><surname>Owe-Larsson</surname><given-names>B</given-names></name><name><surname>Hill</surname><given-names>RH</given-names></name><name><surname>Kristensson</surname><given-names>K</given-names></name></person-group>
<article-title>Changes in calcium currents and GABAergic spontaneous activity in cultured rat hippocampal neurons after a neurotropic influenza A virus infection</article-title>. <source/>Brain Res Bull (<year>2001</year>) <volume>55</volume>(<issue>3</issue>):<page-range>421–9</page-range>. <pub-id pub-id-type="doi">10.1016/S0361-9230(01)00536-6</pub-id>
</mixed-citation>
</ref>
<ref id="B93">
<label>93</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pearce</surname><given-names>BD</given-names></name><name><surname>Valadi</surname><given-names>NM</given-names></name><name><surname>Po</surname><given-names>CL</given-names></name><name><surname>Miller</surname><given-names>AH</given-names></name></person-group>
<article-title>Viral infection of developing GABAergic neurons in a model of hippocampal disinhibition</article-title>. <source/>Neuroreport (<year>2000</year>) <volume>11</volume>(<issue>11</issue>):<page-range>2433–8</page-range>. <pub-id pub-id-type="doi">10.1097/00001756-200008030-00019</pub-id>
</mixed-citation>
</ref>
<ref id="B94">
<label>94</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landreau</surname><given-names>F</given-names></name><name><surname>Galeano</surname><given-names>P</given-names></name><name><surname>Caltana</surname><given-names>LR</given-names></name><name><surname>Masciotra</surname><given-names>L</given-names></name><name><surname>Chertcoff</surname><given-names>A</given-names></name><name><surname>Pontoriero</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Effects of two commonly found strains of influenza A virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia</article-title>. <source/>PloS One (<year>2012</year>) <volume>7</volume>(<issue>12</issue>):<fpage>e51068</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0051068</pub-id>
<pub-id pub-id-type="pmid">23251423</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Canetta</surname><given-names>S</given-names></name><name><surname>Bolkan</surname><given-names>S</given-names></name><name><surname>Padilla-Coreano</surname><given-names>N</given-names></name><name><surname>Song</surname><given-names>LJ</given-names></name><name><surname>Sahn</surname><given-names>R</given-names></name><name><surname>Harrison</surname><given-names>NL</given-names></name><etal></etal></person-group>
<article-title>Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons</article-title>. <source/>Mol Psychiatry (<year>2016</year>) <volume>21</volume>(<issue>7</issue>):<page-range>956–68</page-range>. <pub-id pub-id-type="doi">10.1038/mp.2015.222</pub-id>
</mixed-citation>
</ref>
<ref id="B96">
<label>96</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thion</surname><given-names>MS</given-names></name><name><surname>Mosser</surname><given-names>CA</given-names></name><name><surname>Ferezou</surname><given-names>I</given-names></name><name><surname>Grisel</surname><given-names>P</given-names></name><name><surname>Baptista</surname><given-names>S</given-names></name><name><surname>Low</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Biphasic impact of prenatal inflammation and macrophage depletion on the wiring of neocortical inhibitory circuits</article-title>. <source/>Cell Rep (<year>2019</year>) <volume>28</volume>(<issue>5</issue>):<fpage>1119</fpage>–<lpage>1126 e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.06.086</pub-id>
<pub-id pub-id-type="pmid">31365857</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kowash</surname><given-names>HM</given-names></name><name><surname>Potter</surname><given-names>HG</given-names></name><name><surname>Edye</surname><given-names>ME</given-names></name><name><surname>Prinssen</surname><given-names>EP</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Neill</surname><given-names>JC</given-names></name><etal></etal></person-group>
<article-title>Poly(I:C) source, molecular weight and endotoxin contamination affect dam and prenatal outcomes, implications for models of maternal immune activation</article-title>. <source/>Brain Behav Immun (<year>2019</year>) <volume>82</volume>:<page-range>160–6</page-range>. <pub-id pub-id-type="doi">10.1016/j.bbi.2019.08.006</pub-id>
</mixed-citation>
</ref>
<ref id="B98">
<label>98</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>U</given-names></name><name><surname>Feldon</surname><given-names>J</given-names></name></person-group>
<article-title>To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models</article-title>. <source/>Neuropharmacology (<year>2012</year>) <volume>62</volume>(<issue>3</issue>):<page-range>1308–21</page-range>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.01.009</pub-id>
</mixed-citation>
</ref>
<ref id="B99">
<label>99</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kneeland</surname><given-names>RE</given-names></name><name><surname>Fatemi</surname><given-names>SH</given-names></name></person-group>
<article-title>Viral infection, inflammation and schizophrenia</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry (<year>2013</year>) <volume>42</volume>:<fpage>35</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2012.02.001</pub-id>
<pub-id pub-id-type="pmid">22349576</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cotter</surname><given-names>D</given-names></name><name><surname>Takei</surname><given-names>N</given-names></name><name><surname>Farrell</surname><given-names>M</given-names></name><name><surname>Sham</surname><given-names>P</given-names></name><name><surname>Quinn</surname><given-names>P</given-names></name><name><surname>Larkin</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus?</article-title>
<source/>Schizophr Res (<year>1995</year>) <volume>16</volume>(<issue>3</issue>):<page-range>233–41</page-range>. <pub-id pub-id-type="doi">10.1016/0920-9964(94)E0082-I</pub-id>
</mixed-citation>
</ref>
<ref id="B101">
<label>101</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Sidwell</surname><given-names>R</given-names></name><name><surname>Kist</surname><given-names>D</given-names></name><name><surname>Akhter</surname><given-names>P</given-names></name><name><surname>Meltzer</surname><given-names>HY</given-names></name><name><surname>Bailey</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero</article-title>. <source/>Brain Res (<year>1998</year>) <volume>800</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(98)00450-8</pub-id>
<pub-id pub-id-type="pmid">9685568</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Emamian</surname><given-names>ES</given-names></name><name><surname>Kist</surname><given-names>D</given-names></name><name><surname>Sidwell</surname><given-names>RW</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><name><surname>Akhter</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice</article-title>. <source/>Mol Psychiatry (<year>1999</year>) <volume>4</volume>(<issue>2</issue>):<page-range>145–54</page-range>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000520</pub-id>
</mixed-citation>
</ref>
<ref id="B103">
<label>103</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Cuadra</surname><given-names>AE</given-names></name><name><surname>El-Fakahany</surname><given-names>EE</given-names></name><name><surname>Sidwell</surname><given-names>RW</given-names></name><name><surname>Thuras</surname><given-names>P</given-names></name></person-group>
<article-title>Prenatal viral infection causes alterations in nNOS expression in developing mouse brains</article-title>. <source/>Neuroreport (<year>2000</year>) <volume>11</volume>(<issue>7</issue>):<page-range>1493–6</page-range>. <pub-id pub-id-type="doi">10.1097/00001756-200005150-00027</pub-id>
</mixed-citation>
</ref>
<ref id="B104">
<label>104</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aronsson</surname><given-names>F</given-names></name><name><surname>Karlsson</surname><given-names>H</given-names></name><name><surname>Ljunggren</surname><given-names>H-G</given-names></name><name><surname>Kristensson</surname><given-names>K</given-names></name></person-group>
<article-title>Persistence of the influenza A/WSN/33 virus RNA at midbrain levels of immunodefective mice</article-title>. <source/>J NeuroViro (<year>2001</year>) <volume>7</volume>(<issue>2</issue>):<page-range>117–24</page-range>. <pub-id pub-id-type="doi">10.1080/13550280152058771</pub-id>
</mixed-citation>
</ref>
<ref id="B105">
<label>105</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Emamian</surname><given-names>ES</given-names></name><name><surname>Sidwell</surname><given-names>RW</given-names></name><name><surname>Kist</surname><given-names>DA</given-names></name><name><surname>Stary</surname><given-names>JM</given-names></name><name><surname>Earle</surname><given-names>JA</given-names></name><etal></etal></person-group>
<article-title>Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice</article-title>. <source/>Mol Psychiatry (<year>2002</year>) <volume>7</volume>(<issue>6</issue>):<page-range>633–40</page-range>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001046</pub-id>
</mixed-citation>
</ref>
<ref id="B106">
<label>106</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Earle</surname><given-names>J</given-names></name><name><surname>Kanodia</surname><given-names>R</given-names></name><name><surname>Kist</surname><given-names>D</given-names></name><name><surname>Emamian</surname><given-names>ES</given-names></name><name><surname>Patterson</surname><given-names>PH</given-names></name><etal></etal></person-group>
<article-title>Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia</article-title>. <source/>Cell Mol Neurobiol (<year>2002</year>) <volume>22</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1023/A:1015337611258</pub-id>
<pub-id pub-id-type="pmid">12064515</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Sidwell</surname><given-names>RW</given-names></name><name><surname>Patterson</surname><given-names>PH</given-names></name></person-group>
<article-title>Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring</article-title>. <source/>J Neurosci (<year>2003</year>) <volume>23</volume>(<issue>1</issue>):<fpage>297</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-01-00297.2003</pub-id>
<pub-id pub-id-type="pmid">12514227</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asp</surname><given-names>L</given-names></name><name><surname>Beraki</surname><given-names>S</given-names></name><name><surname>Aronsson</surname><given-names>F</given-names></name><name><surname>Rosvall</surname><given-names>L</given-names></name><name><surname>Ogren</surname><given-names>SO</given-names></name><name><surname>Kristensson</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>Gene expression changes in brains of mice exposed to a maternal virus infection</article-title>. <source/>Neuroreport (<year>2005</year>) <volume>16</volume>(<issue>10</issue>):<page-range>1111–5</page-range>. <pub-id pub-id-type="doi">10.1097/00001756-200507130-00016</pub-id>
</mixed-citation>
</ref>
<ref id="B109">
<label>109</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Pearce</surname><given-names>DA</given-names></name><name><surname>Brooks</surname><given-names>AI</given-names></name><name><surname>Sidwell</surname><given-names>RW</given-names></name></person-group>
<article-title>Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism</article-title>. <source/>Synapse (<year>2005</year>) <volume>57</volume>(<issue>2</issue>):<page-range>91–9</page-range>. <pub-id pub-id-type="doi">10.1002/syn.20162</pub-id>
</mixed-citation>
</ref>
<ref id="B110">
<label>110</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asp</surname><given-names>L</given-names></name><name><surname>Nellaker</surname><given-names>C</given-names></name><name><surname>Karlsson</surname><given-names>H</given-names></name></person-group>
<article-title>Influenza A virus transactivates the mouse envelope gene encoding syncytin B and its regulator, glial cells missing 1</article-title>. <source/>J Neurovirol (<year>2007</year>) <volume>13</volume>(<issue>1</issue>):<fpage>29</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1080/13550280601103125</pub-id>
<pub-id pub-id-type="pmid">17454446</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Reutiman</surname><given-names>TJ</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Mori</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders</article-title>. <source/>Schizophr Res (<year>2008</year>) <volume>99</volume>(<issue>1-3</issue>):<fpage>56</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2007.11.018</pub-id>
<pub-id pub-id-type="pmid">18248790</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><name><surname>Reutiman</surname><given-names>TJ</given-names></name><name><surname>Sidwell</surname><given-names>RW</given-names></name></person-group>
<article-title>Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin</article-title>. <source/>Schizophr Res (<year>2008</year>) <volume>98</volume>(<issue>1-3</issue>):<page-range>163–77</page-range>. <pub-id pub-id-type="doi">10.1016/j.schres.2007.09.031</pub-id>
</mixed-citation>
</ref>
<ref id="B113">
<label>113</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Reutiman</surname><given-names>TJ</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><name><surname>Sidwell</surname><given-names>RW</given-names></name></person-group>
<article-title>The role of cerebellar genes in pathology of autism and schizophrenia</article-title>. <source/>Cerebellum (<year>2008</year>) <volume>7</volume>(<issue>3</issue>):<page-range>279–94</page-range>. <pub-id pub-id-type="doi">10.1007/s12311-008-0017-0</pub-id>
</mixed-citation>
</ref>
<ref id="B114">
<label>114</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holtze</surname><given-names>M</given-names></name><name><surname>Asp</surname><given-names>L</given-names></name><name><surname>Schwieler</surname><given-names>L</given-names></name><name><surname>Engberg</surname><given-names>G</given-names></name><name><surname>Karlsson</surname><given-names>H</given-names></name></person-group>
<article-title>Induction of the kynurenine pathway by neurotropic influenza A virus infection</article-title>. <source/>J Neurosci Res (<year>2008</year>) <volume>86</volume>(<issue>16</issue>):<page-range>3674–83</page-range>. <pub-id pub-id-type="doi">10.1002/jnr.21799</pub-id>
</mixed-citation>
</ref>
<ref id="B115">
<label>115</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Winter</surname><given-names>C</given-names></name><name><surname>Reutiman</surname><given-names>TJ</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><name><surname>Sohr</surname><given-names>R</given-names></name><name><surname>Wolf</surname><given-names>RJ</given-names></name><name><surname>Juckel</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Dopamine and serotonin levels following prenatal viral infection in mouse–implications for psychiatric disorders such as schizophrenia and autism</article-title>. <source/>Eur Neuropsychopharmacol (<year>2008</year>) <volume>18</volume>(<issue>10</issue>):<page-range>712–6</page-range>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2008.06.001</pub-id>
</mixed-citation>
</ref>
<ref id="B116">
<label>116</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asp</surname><given-names>L</given-names></name><name><surname>Beraki</surname><given-names>S</given-names></name><name><surname>Kristensson</surname><given-names>K</given-names></name><name><surname>Ogren</surname><given-names>SO</given-names></name><name><surname>Karlsson</surname><given-names>H</given-names></name></person-group>
<article-title>Neonatal infection with neurotropic influenza A virus affects working memory and expression of type III Nrg1 in adult mice</article-title>. <source/>Brain Behav Immun (<year>2009</year>) <volume>23</volume>(<issue>6</issue>):<page-range>733–41</page-range>. <pub-id pub-id-type="doi">10.1016/j.bbi.2009.04.004</pub-id>
</mixed-citation>
</ref>
<ref id="B117">
<label>117</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>SE</given-names></name><name><surname>Malkova</surname><given-names>N</given-names></name><name><surname>Tse</surname><given-names>D</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Patterson</surname><given-names>PH</given-names></name></person-group>
<article-title>Activation of the maternal immune system alters cerebellar development in the offspring</article-title>. <source/>Brain Behav Immun (<year>2009</year>) <volume>23</volume>(<issue>1</issue>):<page-range>116–23</page-range>. <pub-id pub-id-type="doi">10.1016/j.bbi.2008.07.012</pub-id>
</mixed-citation>
</ref>
<ref id="B118">
<label>118</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><name><surname>Reutiman</surname><given-names>TJ</given-names></name><name><surname>Abu-Odeh</surname><given-names>D</given-names></name><name><surname>Mori</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice</article-title>. <source/>Schizophr Res (<year>2009</year>) <volume>112</volume>(<issue>1-3</issue>):<fpage>46</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2009.04.014</pub-id>
<pub-id pub-id-type="pmid">19487109</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><name><surname>Reutiman</surname><given-names>TJ</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Mori</surname><given-names>S</given-names></name></person-group>
<article-title>Prenatal viral infection of mice at E16 causes changes in gene expression in hippocampi of the offspring</article-title>. <source/>Eur Neuropsychopharmacol (<year>2009</year>) <volume>19</volume>(<issue>9</issue>):<page-range>648–53</page-range>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2009.03.004</pub-id>
</mixed-citation>
</ref>
<ref id="B120">
<label>120</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asp</surname><given-names>L</given-names></name><name><surname>Holtze</surname><given-names>M</given-names></name><name><surname>Powell</surname><given-names>SB</given-names></name><name><surname>Karlsson</surname><given-names>H</given-names></name><name><surname>Erhardt</surname><given-names>S</given-names></name></person-group>
<article-title>Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice</article-title>. <source/>Int J Neuropsychopharmacol (<year>2010</year>) <volume>13</volume>(<issue>4</issue>):<page-range>475–85</page-range>. <pub-id pub-id-type="doi">10.1017/S1461145709990253</pub-id>
</mixed-citation>
</ref>
<ref id="B121">
<label>121</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moreno</surname><given-names>JL</given-names></name><name><surname>Kurita</surname><given-names>M</given-names></name><name><surname>Holloway</surname><given-names>T</given-names></name><name><surname>Lopez</surname><given-names>J</given-names></name><name><surname>Cadagan</surname><given-names>R</given-names></name><name><surname>Martinez-Sobrido</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT(2)A and mGlu(2) receptors in the adult offspring</article-title>. <source/>J Neurosci (<year>2011</year>) <volume>31</volume>(<issue>5</issue>):<page-range>1863–72</page-range>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4230-10.2011</pub-id>
</mixed-citation>
</ref>
<ref id="B122">
<label>122</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><name><surname>Rooney</surname><given-names>RJ</given-names></name><name><surname>Mori</surname><given-names>S</given-names></name><name><surname>Kornfield</surname><given-names>TE</given-names></name><name><surname>Reutiman</surname><given-names>TJ</given-names></name><etal></etal></person-group>
<article-title>The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring</article-title>. <source/>Neuropharmacology (<year>2012</year>) <volume>62</volume>(<issue>3</issue>):<page-range>1290–8</page-range>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.01.011</pub-id>
</mixed-citation>
</ref>
<ref id="B123">
<label>123</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>SH</given-names></name><name><surname>Folsom</surname><given-names>TD</given-names></name><name><surname>Liesch</surname><given-names>SB</given-names></name><name><surname>Kneeland</surname><given-names>RE</given-names></name><name><surname>Karkhane Yousefi</surname><given-names>M</given-names></name><name><surname>Thuras</surname><given-names>PD</given-names></name></person-group>
<article-title>The effects of prenatal H1N1 infection at E16 on FMRP, glutamate, GABA, and reelin signaling systems in developing murine cerebellum</article-title>. <source/>J Neurosci Res (<year>2017</year>) <volume>95</volume>(<issue>5</issue>):<page-range>1110–22</page-range>. <pub-id pub-id-type="doi">10.1002/jnr.23949</pub-id>
</mixed-citation>
</ref>
<ref id="B124">
<label>124</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vernon</surname><given-names>AC</given-names></name><name><surname>So</surname><given-names>PW</given-names></name><name><surname>Lythgoe</surname><given-names>DJ</given-names></name><name><surname>Chege</surname><given-names>W</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Williams</surname><given-names>SC</given-names></name><etal></etal></person-group>
<article-title>Longitudinal in vivo maturational changes of metabolites in the prefrontal cortex of rats exposed to polyinosinic-polycytidylic acid in utero</article-title>. <source/>Eur Neuropsychopharmacol (<year>2015</year>) <volume>25</volume>(<issue>12</issue>):<page-range>2210–20</page-range>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2015.09.022</pub-id>
</mixed-citation>
</ref>
<ref id="B125">
<label>125</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crum</surname><given-names>WR</given-names></name><name><surname>Sawiak</surname><given-names>SJ</given-names></name><name><surname>Chege</surname><given-names>W</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Williams</surname><given-names>SCR</given-names></name><name><surname>Vernon</surname><given-names>AC</given-names></name></person-group>
<article-title>Evolution of structural abnormalities in the rat brain following in utero exposure to maternal immune activation: a longitudinal in vivo MRI study</article-title>. <source/>Brain Behav Immun (<year>2017</year>) <volume>63</volume>:<page-range>50–9</page-range>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.12.008</pub-id>
</mixed-citation>
</ref>
<ref id="B126">
<label>126</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Piontkewitz</surname><given-names>Y</given-names></name><name><surname>Arad</surname><given-names>M</given-names></name><name><surname>Weiner</surname><given-names>I</given-names></name></person-group>
<article-title>Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia</article-title>. <source/>Schizophr Bull (<year>2011</year>) <volume>37</volume>(<issue>6</issue>):<page-range>1257–69</page-range>. <pub-id pub-id-type="doi">10.1093/schbul/sbq040</pub-id>
</mixed-citation>
</ref>
<ref id="B127">
<label>127</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Graham</surname><given-names>AM</given-names></name><name><surname>Rasmussen</surname><given-names>JM</given-names></name><name><surname>Rudolph</surname><given-names>MD</given-names></name><name><surname>Heim</surname><given-names>CM</given-names></name><name><surname>Gilmore</surname><given-names>JH</given-names></name><name><surname>Styner</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Maternal systemic interleukin-6 during pregnancy is associated with newborn amygdala phenotypes and subsequent behavior at 2 years of age</article-title>. <source/>Biol Psychiatry (<year>2018</year>) <volume>83</volume>(<issue>2</issue>):<page-range>109–19</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.05.027</pub-id>
</mixed-citation>
</ref>
<ref id="B128">
<label>128</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Graham</surname><given-names>AM</given-names></name><name><surname>Rasmussen</surname><given-names>JM</given-names></name><name><surname>Entringer</surname><given-names>S</given-names></name><name><surname>Ben Ward</surname><given-names>E</given-names></name><name><surname>Rudolph</surname><given-names>MD</given-names></name><name><surname>Gilmore</surname><given-names>JH</given-names></name><etal></etal></person-group>
<article-title>Maternal cortisol concentrations during pregnancy and sex-specific associations with neonatal amygdala connectivity and emerging internalizing behaviors</article-title>. <source/>Biol Psychiatry (<year>2019</year>) <volume>85</volume>(<issue>2</issue>):<page-range>172–81</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2018.06.023</pub-id>
</mixed-citation>
</ref>
<ref id="B129">
<label>129</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Urakubo</surname><given-names>A</given-names></name><name><surname>Jarskog</surname><given-names>LF</given-names></name><name><surname>Lieberman</surname><given-names>JA</given-names></name><name><surname>Gilmore</surname><given-names>JH</given-names></name></person-group>
<article-title>Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain</article-title>. <source/>Schizophr Res (<year>2001</year>) <volume>47</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/S0920-9964(00)00032-3</pub-id>
<pub-id pub-id-type="pmid">11163542</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garay</surname><given-names>PA</given-names></name><name><surname>Hsiao</surname><given-names>EY</given-names></name><name><surname>Patterson</surname><given-names>PH</given-names></name><name><surname>McAllister</surname><given-names>AK</given-names></name></person-group>
<article-title>Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development</article-title>. <source/>Brain Behav Immun (<year>2013</year>) <volume>31</volume>:<fpage>54</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2012.07.008</pub-id>
<pub-id pub-id-type="pmid">22841693</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>U</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Urwyler</surname><given-names>A</given-names></name><name><surname>Yee</surname><given-names>BK</given-names></name><name><surname>Schedlowski</surname><given-names>M</given-names></name><name><surname>Feldon</surname><given-names>J</given-names></name></person-group>
<article-title>Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling</article-title>. <source/>Mol Psychiatry (<year>2008</year>) <volume>13</volume>(<issue>2</issue>):<page-range>208–21</page-range>. <pub-id pub-id-type="doi">10.1038/sj.mp.4002042</pub-id>
</mixed-citation>
</ref>
<ref id="B132">
<label>132</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mondelli</surname><given-names>V</given-names></name><name><surname>Vernon</surname><given-names>AC</given-names></name><name><surname>Turkheimer</surname><given-names>F</given-names></name><name><surname>Dazzan</surname><given-names>P</given-names></name><name><surname>Pariante</surname><given-names>CM</given-names></name></person-group>
<article-title>Brain microglia in psychiatric disorders</article-title>. <source/>Lancet Psychiatry (<year>2017</year>) <volume>4</volume>(<issue>7</issue>):<page-range>563–72</page-range>. <pub-id pub-id-type="doi">10.1016/S2215-0366(17)30101-3</pub-id>
</mixed-citation>
</ref>
<ref id="B133">
<label>133</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matcovitch-Natan</surname><given-names>O</given-names></name><name><surname>Winter</surname><given-names>DR</given-names></name><name><surname>Giladi</surname><given-names>A</given-names></name><name><surname>Vargas Aguilar</surname><given-names>S</given-names></name><name><surname>Spinrad</surname><given-names>A</given-names></name><name><surname>Sarrazin</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Microglia development follows a stepwise program to regulate brain homeostasis</article-title>. <source/>Science (<year>2016</year>) <volume>353</volume>(<issue>6301</issue>):<fpage>aad8670</fpage>. <pub-id pub-id-type="doi">10.1126/science.aad8670</pub-id>
<pub-id pub-id-type="pmid">27338705</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mattei</surname><given-names>D</given-names></name><name><surname>Ivanov</surname><given-names>A</given-names></name><name><surname>Ferrai</surname><given-names>C</given-names></name><name><surname>Jordan</surname><given-names>P</given-names></name><name><surname>Guneykaya</surname><given-names>D</given-names></name><name><surname>Buonfiglioli</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment</article-title>. <source/>Transl Psychiatry (<year>2017</year>) <volume>7</volume>(<issue>5</issue>):<fpage>e1120</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2017.80</pub-id>
<pub-id pub-id-type="pmid">28485733</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>WY</given-names></name><name><surname>Chang</surname><given-names>YC</given-names></name><name><surname>Lee</surname><given-names>LJ</given-names></name><name><surname>Lee</surname><given-names>LJ</given-names></name></person-group>
<article-title>Prenatal infection affects the neuronal architecture and cognitive function in adult mice</article-title>. <source/>Dev Neurosci (<year>2014</year>) <volume>36</volume>(<issue>5</issue>):<page-range>359–70</page-range>. <pub-id pub-id-type="doi">10.1159/000362383</pub-id>
</mixed-citation>
</ref>
<ref id="B136">
<label>136</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Juckel</surname><given-names>G</given-names></name><name><surname>Manitz</surname><given-names>MP</given-names></name><name><surname>Brune</surname><given-names>M</given-names></name><name><surname>Friebe</surname><given-names>A</given-names></name><name><surname>Heneka</surname><given-names>MT</given-names></name><name><surname>Wolf</surname><given-names>RJ</given-names></name></person-group>
<article-title>Microglial activation in a neuroinflammational animal model of schizophrenia–a pilot study</article-title>. <source/>Schizophr Res (<year>2011</year>) <volume>131</volume>(<issue>1-3</issue>):<fpage>96</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2011.06.018</pub-id>
<pub-id pub-id-type="pmid">21752601</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van den Eynde</surname><given-names>K</given-names></name><name><surname>Missault</surname><given-names>S</given-names></name><name><surname>Fransen</surname><given-names>E</given-names></name><name><surname>Raeymaekers</surname><given-names>L</given-names></name><name><surname>Willems</surname><given-names>R</given-names></name><name><surname>Drinkenburg</surname><given-names>W</given-names></name><etal></etal></person-group>
<article-title>Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia</article-title>. <source/>Behav Brain Res (<year>2014</year>) <volume>258</volume>:<page-range>179–86</page-range>. <pub-id pub-id-type="doi">10.1016/j.bbr.2013.10.005</pub-id>
</mixed-citation>
</ref>
<ref id="B138">
<label>138</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giovanoli</surname><given-names>S</given-names></name><name><surname>Notter</surname><given-names>T</given-names></name><name><surname>Richetto</surname><given-names>J</given-names></name><name><surname>Labouesse</surname><given-names>MA</given-names></name><name><surname>Vuillermot</surname><given-names>S</given-names></name><name><surname>Riva</surname><given-names>MA</given-names></name><etal></etal></person-group>
<article-title>Late prenatal immune activation causes hippocampal deficits in the absence of persistent inflammation across aging</article-title>. <source/>J Neuroinflamm (<year>2015</year>) <volume>12</volume>:<fpage>221</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0437-y</pub-id>
</mixed-citation>
</ref>
<ref id="B139">
<label>139</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Notter</surname><given-names>T</given-names></name><name><surname>Coughlin</surname><given-names>JM</given-names></name><name><surname>Gschwind</surname><given-names>T</given-names></name><name><surname>Weber-Stadlbauer</surname><given-names>U</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kassiou</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia</article-title>. <source/>Mol Psychiatry (<year>2017</year>) <volume>23</volume>(<issue>2</issue>):<lpage>323–4</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.248</pub-id>
</mixed-citation>
</ref>
<ref id="B140">
<label>140</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>A</given-names></name><name><surname>Pillai</surname><given-names>PS</given-names></name></person-group>
<article-title>Innate immunity to influenza virus infection</article-title>. <source/>Nat Rev Immunol (<year>2014</year>) <volume>14</volume>:<fpage>315</fpage>. <pub-id pub-id-type="doi">10.1038/nri3665</pub-id>
<pub-id pub-id-type="pmid">24762827</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schroder</surname><given-names>K</given-names></name><name><surname>Sweet</surname><given-names>MJ</given-names></name><name><surname>Hume</surname><given-names>DA</given-names></name></person-group>
<article-title>Signal integration between IFNgamma and TLR signalling pathways in macrophages</article-title>. <source/>Immunobiology (<year>2006</year>) <volume>211</volume>(<issue>6-8</issue>):<page-range>511–24</page-range>. <pub-id pub-id-type="doi">10.1016/j.imbio.2006.05.007</pub-id>
</mixed-citation>
</ref>
<ref id="B142">
<label>142</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perry</surname><given-names>VH</given-names></name><name><surname>Nicoll</surname><given-names>JA</given-names></name><name><surname>Holmes</surname><given-names>C</given-names></name></person-group>
<article-title>Microglia in neurodegenerative disease</article-title>. <source/>Nat Rev Neurol (<year>2010</year>) <volume>6</volume>(<issue>4</issue>):<fpage>193</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2010.17</pub-id>
<pub-id pub-id-type="pmid">20234358</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salam</surname><given-names>AP</given-names></name><name><surname>Borsini</surname><given-names>A</given-names></name><name><surname>Zunszain</surname><given-names>PA</given-names></name></person-group>
<article-title>Trained innate immunity: a salient factor in the pathogenesis of neuroimmune psychiatric disorders</article-title>. <source/>Mol Psychiatry (<year>2018</year>) <volume>23</volume>(<issue>2</issue>):<page-range>170–6</page-range>. <pub-id pub-id-type="doi">10.1038/mp.2017.186</pub-id>
</mixed-citation>
</ref>
<ref id="B144">
<label>144</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weinhard</surname><given-names>L</given-names></name><name><surname>di Bartolomei</surname><given-names>G</given-names></name><name><surname>Bolasco</surname><given-names>G</given-names></name><name><surname>Machado</surname><given-names>P</given-names></name><name><surname>Schieber</surname><given-names>NL</given-names></name><name><surname>Neniskyte</surname><given-names>U</given-names></name><etal></etal></person-group>
<article-title>Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction</article-title>. <source/>Nat Commun (<year>2018</year>) <volume>9</volume>(<issue>1</issue>):<fpage>1228</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-03566-5</pub-id>
<pub-id pub-id-type="pmid">29581545</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schafer</surname><given-names>DP</given-names></name><name><surname>Lehrman</surname><given-names>EK</given-names></name><name><surname>Kautzman</surname><given-names>AG</given-names></name><name><surname>Koyama</surname><given-names>R</given-names></name><name><surname>Mardinly</surname><given-names>AR</given-names></name><name><surname>Yamasaki</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner</article-title>. <source/>Neuron (<year>2012</year>) <volume>74</volume>(<issue>4</issue>):<fpage>691</fpage>–<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.026</pub-id>
<pub-id pub-id-type="pmid">22632727</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhan</surname><given-names>Y</given-names></name><name><surname>Paolicelli</surname><given-names>RC</given-names></name><name><surname>Sforazzini</surname><given-names>F</given-names></name><name><surname>Weinhard</surname><given-names>L</given-names></name><name><surname>Bolasco</surname><given-names>G</given-names></name><name><surname>Pagani</surname><given-names>F</given-names></name><etal></etal></person-group>
<article-title>Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior</article-title>. <source/>Nat Neurosci (<year>2014</year>) <volume>17</volume>(<issue>3</issue>):<page-range>400–6</page-range>. <pub-id pub-id-type="doi">10.1038/nn.3641</pub-id>
</mixed-citation>
</ref>
<ref id="B147">
<label>147</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilton</surname><given-names>DK</given-names></name><name><surname>Dissing-Olesen</surname><given-names>L</given-names></name><name><surname>Stevens</surname><given-names>B</given-names></name></person-group>
<article-title>Neuron-Glia signaling in synapse elimination</article-title>. <source/>Annu Rev Neurosci (<year>2019</year>) <volume>42</volume>:<page-range>107–27</page-range>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-070918-050306</pub-id>
</mixed-citation>
</ref>
<ref id="B148">
<label>148</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glantz</surname><given-names>LA</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name></person-group>
<article-title>Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia</article-title>. <source/>Arch Gen Psychiatry (<year>2000</year>) <volume>57</volume>(<issue>1</issue>):<fpage>65</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.57.1.65</pub-id>
<pub-id pub-id-type="pmid">10632234</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sellgren</surname><given-names>CM</given-names></name><name><surname>Gracias</surname><given-names>J</given-names></name><name><surname>Watmuff</surname><given-names>B</given-names></name><name><surname>Biag</surname><given-names>JD</given-names></name><name><surname>Thanos</surname><given-names>JM</given-names></name><name><surname>Whittredge</surname><given-names>PB</given-names></name><etal></etal></person-group>
<article-title>Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning</article-title>. <source/>Nat Neurosci (<year>2019</year>) <volume>22</volume>(<issue>3</issue>):<page-range>374–85</page-range>. <pub-id pub-id-type="doi">10.1038/s41593-018-0334-7</pub-id>
</mixed-citation>
</ref>
<ref id="B150">
<label>150</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>A</given-names></name><name><surname>Wake</surname><given-names>H</given-names></name><name><surname>Ishikawa</surname><given-names>AW</given-names></name><name><surname>Eto</surname><given-names>K</given-names></name><name><surname>Shibata</surname><given-names>K</given-names></name><name><surname>Murakoshi</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Microglia contact induces synapse formation in developing somatosensory cortex</article-title>. <source/>Nat Commun (<year>2016</year>) <volume>7</volume>:<fpage>12540</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms12540</pub-id>
<pub-id pub-id-type="pmid">27558646</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Wright</surname><given-names>P</given-names></name><name><surname>Laing</surname><given-names>P</given-names></name><name><surname>Donaldson</surname><given-names>PT</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name></person-group>
<article-title>Schizophrenia: the teratogenic antibody hypothesis</article-title>. In: <person-group person-group-type="editor"><name><surname>Müller</surname><given-names>N</given-names></name></person-group>, editor. <source/>Psychiatry Psychoimmunology and Viruses. Key Topics in Brain Research. <publisher-loc>Vienna</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>1999</year>). p. <fpage>89</fpage>–<lpage>99</lpage>.</mixed-citation>
</ref>
<ref id="B152">
<label>152</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>AS</given-names></name><name><surname>Begg</surname><given-names>MD</given-names></name><name><surname>Gravenstein</surname><given-names>S</given-names></name><name><surname>Schaefer</surname><given-names>CA</given-names></name><name><surname>Wyatt</surname><given-names>RJ</given-names></name><name><surname>Bresnahan</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Serologic-evidence of prenatal influenza in the etiology of schizophrenia</article-title>. <source/>Arch Gen Psychiatry (<year>2004</year>) <volume>61</volume>(<issue>8</issue>):<page-range>774–80</page-range>. <pub-id pub-id-type="doi">10.1001/archpsyc.61.8.774</pub-id>
</mixed-citation>
</ref>
<ref id="B153">
<label>153</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wright</surname><given-names>P</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name></person-group>
<article-title>Schizophrenia: prenatal influenza and autoimmunity</article-title>. <source/>Ann Med (<year>1993</year>) <volume>25</volume>(<issue>5</issue>):<fpage>497</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.3109/07853899309147318</pub-id>
<pub-id pub-id-type="pmid">8251151</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trevathan</surname><given-names>RD</given-names></name><name><surname>Tatum</surname><given-names>JC</given-names></name></person-group>
<article-title>Rarity of concurrence of psychosis and rheumatoid arthritis in individual patients; report of a case</article-title>. <source/>J Nerv Ment Dis (<year>1954</year>) <volume>120</volume>(<issue>1-2</issue>):<page-range>83–4</page-range>.</mixed-citation>
</ref>
<ref id="B155">
<label>155</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pilkington</surname><given-names>TL</given-names></name></person-group>
<article-title>The coincidence of rheumatoid-arthritis and schizophrenia</article-title>. <source/>J Nerv Ment Dis (<year>1956</year>) <volume>124</volume>(<issue>6</issue>):<page-range>604–6</page-range>. <pub-id pub-id-type="doi">10.1097/00005053-195612000-00007</pub-id>
</mixed-citation>
</ref>
<ref id="B156">
<label>156</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Graff</surname><given-names>H</given-names></name><name><surname>Handford</surname><given-names>A</given-names></name></person-group>
<article-title>Celiac syndrome in the case histories of five schizophrenics</article-title>. <source/>Psychiatr Q (<year>1961</year>) <volume>35</volume>:<page-range>306–13</page-range>. <pub-id pub-id-type="doi">10.1007/BF01566581</pub-id>
</mixed-citation>
</ref>
<ref id="B157">
<label>157</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cullen</surname><given-names>AE</given-names></name><name><surname>Holmes</surname><given-names>S</given-names></name><name><surname>Pollak</surname><given-names>TA</given-names></name><name><surname>Blackman</surname><given-names>G</given-names></name><name><surname>Joyce</surname><given-names>DW</given-names></name><name><surname>Kempton</surname><given-names>MJ</given-names></name><etal></etal></person-group>
<article-title>Associations between non-neurological autoimmune disorders and psychosis: a meta-analysis</article-title>. <source/>Biol Psychiatry (<year>2019</year>) <volume>85</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2018.06.016</pub-id>
<pub-id pub-id-type="pmid">30122288</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benros</surname><given-names>ME</given-names></name><name><surname>Nielsen</surname><given-names>PR</given-names></name><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>Eaton</surname><given-names>WW</given-names></name><name><surname>Dalton</surname><given-names>SO</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name></person-group>
<article-title>Autoimmune Diseases and Severe Infections as Risk Factors for Schizophrenia: A 30-Year Population-Based Register Study</article-title>. <source/>Am J Psychiatry (<year>2011</year>) <volume>168</volume>(<issue>12</issue>):<page-range>1303–10</page-range>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2011.11030516</pub-id>
</mixed-citation>
</ref>
<ref id="B159">
<label>159</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Graus</surname><given-names>F</given-names></name><name><surname>Saiz</surname><given-names>A</given-names></name><name><surname>Dalmau</surname><given-names>J</given-names></name></person-group>
<article-title>Antibodies and neuronal autoimmune disorders of the CNS</article-title>. <source/>J Neurol (<year>2010</year>) <volume>257</volume>(<issue>4</issue>):<page-range>509–17</page-range>. <pub-id pub-id-type="doi">10.1007/s00415-009-5431-9</pub-id>
</mixed-citation>
</ref>
<ref id="B160">
<label>160</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steiner</surname><given-names>J</given-names></name><name><surname>Walter</surname><given-names>M</given-names></name><name><surname>Glanz</surname><given-names>W</given-names></name><name><surname>Sarnyai</surname><given-names>Z</given-names></name><name><surname>Bernstein</surname><given-names>HG</given-names></name><name><surname>Vielhaber</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis</article-title>. <source/>JAMA Psychiatry (<year>2013</year>) <volume>70</volume>(<issue>3</issue>):<page-range>271–8</page-range>. <pub-id pub-id-type="doi">10.1001/2013.jamapsychiatry.86</pub-id>
</mixed-citation>
</ref>
<ref id="B161">
<label>161</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zandi</surname><given-names>MS</given-names></name><name><surname>Irani</surname><given-names>SR</given-names></name><name><surname>Lang</surname><given-names>B</given-names></name><name><surname>Waters</surname><given-names>P</given-names></name><name><surname>Jones</surname><given-names>PB</given-names></name><name><surname>McKenna</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Disease-relevant autoantibodies in first episode schizophrenia</article-title>. <source/>J Neurol (<year>2011</year>) <volume>258</volume>(<issue>4</issue>):<page-range>686–8</page-range>. <pub-id pub-id-type="doi">10.1007/s00415-010-5788-9</pub-id>
</mixed-citation>
</ref>
<ref id="B162">
<label>162</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pollak</surname><given-names>TA</given-names></name><name><surname>Rogers</surname><given-names>JP</given-names></name><name><surname>Nagele</surname><given-names>RG</given-names></name><name><surname>Peakman</surname><given-names>M</given-names></name><name><surname>Stone</surname><given-names>JM</given-names></name><name><surname>David</surname><given-names>AS</given-names></name><etal></etal></person-group>
<article-title>Antibodies in the diagnosis, prognosis, and prediction of psychotic disorders</article-title>. <source/>Schizophr Bull (<year>2019</year>) <volume>45</volume>(<issue>1</issue>):<page-range>233–46</page-range>. <pub-id pub-id-type="doi">10.1093/schbul/sby021</pub-id>
</mixed-citation>
</ref>
<ref id="B163">
<label>163</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pollak</surname><given-names>TA</given-names></name><name><surname>McCormack</surname><given-names>R</given-names></name><name><surname>Peakman</surname><given-names>M</given-names></name><name><surname>Nicholson</surname><given-names>TR</given-names></name><name><surname>David</surname><given-names>AS</given-names></name></person-group>
<article-title>Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis</article-title>. <source/>Psychol Med (<year>2014</year>) <volume>44</volume>(<issue>12</issue>):<page-range>2475–87</page-range>. <pub-id pub-id-type="doi">10.1017/S003329171300295X</pub-id>
</mixed-citation>
</ref>
<ref id="B164">
<label>164</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Diwani</surname><given-names>A</given-names></name><name><surname>Pollak</surname><given-names>TA</given-names></name><name><surname>Langford</surname><given-names>AE</given-names></name><name><surname>Lennox</surname><given-names>BR</given-names></name></person-group>
<article-title>Synaptic and neuronal autoantibody-associated psychiatric syndromes: controversies and hypotheses</article-title>. <source/>Front Psychiatry (<year>2017</year>) <volume>8</volume>:<elocation-id>13</elocation-id>. <pub-id pub-id-type="doi">10.3389/fpsyt.2017.00013</pub-id>
<pub-id pub-id-type="pmid">28220082</pub-id></mixed-citation>
</ref>
<ref id="B165">
<label>165</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coutinho</surname><given-names>E</given-names></name><name><surname>Harrison</surname><given-names>P</given-names></name><name><surname>Vincent</surname><given-names>A</given-names></name></person-group>
<article-title>Do neuronal autoantibodies cause psychosis? a neuroimmunological perspective</article-title>. <source/>Biol Psychiatry (<year>2014</year>) <volume>75</volume>(<issue>4</issue>):<page-range>269–75</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.07.040</pub-id>
</mixed-citation>
</ref>
<ref id="B166">
<label>166</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deakin</surname><given-names>J</given-names></name><name><surname>Lennox</surname><given-names>BR</given-names></name><name><surname>Zandi</surname><given-names>MS</given-names></name></person-group>
<article-title>Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis</article-title>. <source/>Biol Psychiatry (<year>2014</year>) <volume>75</volume>(<issue>4</issue>):<page-range>284–91</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.07.018</pub-id>
</mixed-citation>
</ref>
<ref id="B167">
<label>167</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Höftberger</surname><given-names>R</given-names></name><name><surname>van Sonderen</surname><given-names>A</given-names></name><name><surname>Leypoldt</surname><given-names>F</given-names></name><name><surname>Houghton</surname><given-names>D</given-names></name><name><surname>Geschwind</surname><given-names>M</given-names></name><name><surname>Gelfand</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Encephalitis and AMPA receptor antibodies Novel findings in a case series of 22 patients</article-title>. <source/>Neurology (<year>2015</year>) <volume>84</volume>(<issue>24</issue>):<page-range>2403–12</page-range>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000001682</pub-id>
</mixed-citation>
</ref>
<ref id="B168">
<label>168</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kayser</surname><given-names>MS</given-names></name><name><surname>Dalmau</surname><given-names>J</given-names></name></person-group>
<article-title>Anti-NMDA receptor encephalitis, autoimmunity, and psychosis</article-title>. <source/>Schizophr Res (<year>2016</year>) <volume>176</volume>(<issue>1</issue>):<fpage>36</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2014.10.007</pub-id>
<pub-id pub-id-type="pmid">25458857</pub-id></mixed-citation>
</ref>
<ref id="B169">
<label>169</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pollak</surname><given-names>TA</given-names></name><name><surname>Beck</surname><given-names>K</given-names></name><name><surname>Irani</surname><given-names>SR</given-names></name><name><surname>Howes</surname><given-names>OD</given-names></name><name><surname>David</surname><given-names>AS</given-names></name><name><surname>McGuire</surname><given-names>PK</given-names></name></person-group>
<article-title>Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications</article-title>. <source/>Psychopharmacol (Berl) (<year>2016</year>) <volume>233</volume>(<issue>9</issue>):<page-range>1605–21</page-range>. <pub-id pub-id-type="doi">10.1007/s00213-015-4156-y</pub-id>
</mixed-citation>
</ref>
<ref id="B170">
<label>170</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kayser</surname><given-names>MS</given-names></name><name><surname>Titulaer</surname><given-names>MJ</given-names></name><name><surname>Gresa-Arribas</surname><given-names>N</given-names></name><name><surname>Dalmau</surname><given-names>J</given-names></name></person-group>
<article-title>Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis</article-title>. <source/>JAMA Neurol (<year>2013</year>) <volume>70</volume>(<issue>9</issue>):<page-range>1133–9</page-range>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2013.3216</pub-id>
</mixed-citation>
</ref>
<ref id="B171">
<label>171</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Titulaer</surname><given-names>MJ</given-names></name><name><surname>McCracken</surname><given-names>L</given-names></name><name><surname>Gabilondo</surname><given-names>I</given-names></name><name><surname>Armangue</surname><given-names>T</given-names></name><name><surname>Glaser</surname><given-names>C</given-names></name><name><surname>Iizuka</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study</article-title>. <source/>Lancet Neurol (<year>2013</year>) <volume>12</volume>(<issue>2</issue>):<page-range>157–65</page-range>. <pub-id pub-id-type="doi">10.1016/S1474-4422(12)70310-1</pub-id>
</mixed-citation>
</ref>
<ref id="B172">
<label>172</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Diwani</surname><given-names>A</given-names></name><name><surname>Handel</surname><given-names>A</given-names></name><name><surname>Townsend</surname><given-names>L</given-names></name><name><surname>Pollak</surname><given-names>T</given-names></name><name><surname>Leite</surname><given-names>MI</given-names></name><name><surname>Harrison</surname><given-names>PJ</given-names></name><etal></etal></person-group>
<article-title>The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data</article-title>. <source/>Lancet Psychiatry (<year>2019</year>) <volume>6</volume>(<issue>3</issue>):<page-range>235–46</page-range>. <pub-id pub-id-type="doi">10.1016/S2215-0366(19)30001-X</pub-id>
</mixed-citation>
</ref>
<ref id="B173">
<label>173</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dalmau</surname><given-names>J</given-names></name><name><surname>Gleichman</surname><given-names>AJ</given-names></name><name><surname>Hughes</surname><given-names>EG</given-names></name><name><surname>Rossi</surname><given-names>JE</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Lai</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies</article-title>. <source/>Lancet Neurol (<year>2008</year>) <volume>7</volume>(<issue>12</issue>):<page-range>1091–8</page-range>. <pub-id pub-id-type="doi">10.1016/S1474-4422(08)70224-2</pub-id>
</mixed-citation>
</ref>
<ref id="B174">
<label>174</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dalmau</surname><given-names>J</given-names></name><name><surname>Tuzun</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>HY</given-names></name><name><surname>Masjuan</surname><given-names>J</given-names></name><name><surname>Rossi</surname><given-names>JE</given-names></name><name><surname>Voloschin</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma</article-title>. <source/>Ann Neurol (<year>2007</year>) <volume>61</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21050</pub-id>
<pub-id pub-id-type="pmid">17262855</pub-id></mixed-citation>
</ref>
<ref id="B175">
<label>175</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Armangue</surname><given-names>T</given-names></name><name><surname>Leypoldt</surname><given-names>F</given-names></name><name><surname>Malaga</surname><given-names>I</given-names></name><name><surname>Raspall-Chaure</surname><given-names>M</given-names></name><name><surname>Marti</surname><given-names>I</given-names></name><name><surname>Nichter</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Herpes simplex virus encephalitis is a trigger of brain autoimmunity</article-title>. <source/>Ann Neurol (<year>2014</year>) <volume>75</volume>(<issue>2</issue>):<page-range>317–23</page-range>. <pub-id pub-id-type="doi">10.1002/ana.24083</pub-id>
</mixed-citation>
</ref>
<ref id="B176">
<label>176</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Westman</surname><given-names>G</given-names></name><name><surname>Studahl</surname><given-names>M</given-names></name><name><surname>Ahlm</surname><given-names>C</given-names></name><name><surname>Eriksson</surname><given-names>BM</given-names></name><name><surname>Persson</surname><given-names>B</given-names></name><name><surname>Ronnelid</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>N-Methyl-D-Aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis</article-title>. <source/>Clin Microbiol Infect (<year>2016</year>) <volume>22</volume>(<issue>11</issue>):<page-range>934–40</page-range>. <pub-id pub-id-type="doi">10.1016/j.cmi.2016.07.028</pub-id>
</mixed-citation>
</ref>
<ref id="B177">
<label>177</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salovin</surname><given-names>A</given-names></name><name><surname>Glanzman</surname><given-names>J</given-names></name><name><surname>Roslin</surname><given-names>K</given-names></name><name><surname>Armangue</surname><given-names>T</given-names></name><name><surname>Lynch</surname><given-names>DR</given-names></name><name><surname>Panzer</surname><given-names>JA</given-names></name></person-group>
<article-title>Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection</article-title>. <source/>Neurol Neuroimmunol Neuroinflamm (<year>2018</year>) <volume>5</volume>(<issue>4</issue>):<fpage>e458</fpage>. <pub-id pub-id-type="doi">10.1212/NXI.0000000000000458</pub-id>
<pub-id pub-id-type="pmid">29629396</pub-id></mixed-citation>
</ref>
<ref id="B178">
<label>178</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pruss</surname><given-names>H</given-names></name></person-group>
<article-title>Postviral autoimmune encephalitis: manifestations in children and adults</article-title>. <source/>Curr Opin Neurol (<year>2017</year>) <volume>30</volume>(<issue>3</issue>):<page-range>327–33</page-range>. <pub-id pub-id-type="doi">10.1097/WCO.0000000000000445</pub-id>
</mixed-citation>
</ref>
<ref id="B179">
<label>179</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dalmau</surname><given-names>J</given-names></name><name><surname>Lancaster</surname><given-names>E</given-names></name><name><surname>Martinez-Hernandez</surname><given-names>E</given-names></name><name><surname>Rosenfeld</surname><given-names>MR</given-names></name><name><surname>Balice-Gordon</surname><given-names>R</given-names></name></person-group>
<article-title>Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis</article-title>. <source/>Lancet Neurol (<year>2011</year>) <volume>10</volume>(<issue>1</issue>):<fpage>63</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70253-2</pub-id>
<pub-id pub-id-type="pmid">21163445</pub-id></mixed-citation>
</ref>
<ref id="B180">
<label>180</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baltagi</surname><given-names>SA</given-names></name><name><surname>Shoykhet</surname><given-names>M</given-names></name><name><surname>Felmet</surname><given-names>K</given-names></name><name><surname>Kochanek</surname><given-names>PM</given-names></name><name><surname>Bell</surname><given-names>MJ</given-names></name></person-group>
<article-title>Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic</article-title>. <source/>Pediatr Crit Care Med (<year>2010</year>) <volume>11</volume>(<issue>2</issue>):<page-range>179–84</page-range>. <pub-id pub-id-type="doi">10.1097/PCC.0b013e3181cf4652</pub-id>
</mixed-citation>
</ref>
<ref id="B181">
<label>181</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cartisano</surname><given-names>T</given-names></name><name><surname>Kicker</surname><given-names>J</given-names></name></person-group>
<article-title>Anti-N-methyl-D-aspartate receptor encephalitis in 7-month old infant following influenza vaccination (P5.136)</article-title>. <source/>Neurology (<year>2016</year>) <volume>86</volume>(<issue>16 Supplement</issue>). P5.136.</mixed-citation>
</ref>
<ref id="B182">
<label>182</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hung</surname><given-names>TY</given-names></name><name><surname>Foo</surname><given-names>NH</given-names></name><name><surname>Lai</surname><given-names>MC</given-names></name></person-group>
<article-title>Anti-N-methyl-d-aspartate receptor encephalitis</article-title>. <source/>Pediatr Neonatol (<year>2011</year>) <volume>52</volume>(<issue>6</issue>):<page-range>361–4</page-range>. <pub-id pub-id-type="doi">10.1016/j.pedneo.2011.08.012</pub-id>
</mixed-citation>
</ref>
<ref id="B183">
<label>183</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name></person-group>
<article-title>Anti-NMDA receptor encephalitis and vaccination</article-title>. <source/>Int J Mol Sci (<year>2017</year>) <volume>18</volume>(<issue>1</issue>):<fpage>193</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18010193</pub-id>
</mixed-citation>
</ref>
<ref id="B184">
<label>184</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dale</surname><given-names>RC</given-names></name><name><surname>Irani</surname><given-names>SR</given-names></name><name><surname>Brilot</surname><given-names>F</given-names></name><name><surname>Pillai</surname><given-names>S</given-names></name><name><surname>Webster</surname><given-names>R</given-names></name><name><surname>Gill</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica</article-title>. <source/>Ann Neurol (<year>2009</year>) <volume>66</volume>(<issue>5</issue>):<page-range>704–9</page-range>. <pub-id pub-id-type="doi">10.1002/ana.21807</pub-id>
</mixed-citation>
</ref>
<ref id="B185">
<label>185</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McCall</surname><given-names>S</given-names></name><name><surname>Vilensky</surname><given-names>JA</given-names></name><name><surname>Gilman</surname><given-names>S</given-names></name><name><surname>Taubenberger</surname><given-names>JK</given-names></name></person-group>
<article-title>The relationship between encephalitis lethargica and influenza: a critical analysis</article-title>. <source/>J Neurovirol (<year>2008</year>) <volume>14</volume>(<issue>3</issue>):<page-range>177–85</page-range>. <pub-id pub-id-type="doi">10.1080/13550280801995445</pub-id>
</mixed-citation>
</ref>
<ref id="B186">
<label>186</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pillai</surname><given-names>SC</given-names></name><name><surname>Hacohen</surname><given-names>Y</given-names></name><name><surname>Tantsis</surname><given-names>E</given-names></name><name><surname>Prelog</surname><given-names>K</given-names></name><name><surname>Merheb</surname><given-names>V</given-names></name><name><surname>Kesson</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome</article-title>. <source/>Pediatrics (<year>2015</year>) <volume>135</volume>(<issue>4</issue>):<page-range>e974–84</page-range>. <pub-id pub-id-type="doi">10.1542/peds.2014-2702</pub-id>
</mixed-citation>
</ref>
<ref id="B187">
<label>187</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilson</surname><given-names>N</given-names></name><name><surname>Barnard</surname><given-names>LT</given-names></name><name><surname>Summers</surname><given-names>JA</given-names></name><name><surname>Shanks</surname><given-names>GD</given-names></name><name><surname>Baker</surname><given-names>MG</given-names></name></person-group>
<article-title>Differential mortality rates by ethnicity in 3 influenza pandemics over a century, New Zealand</article-title>. <source/>Emerg Infect Dis (<year>2012</year>) <volume>18</volume>(<issue>1</issue>):<page-range>71–7</page-range>. <pub-id pub-id-type="doi">10.3201/eid1801.110035</pub-id>
</mixed-citation>
</ref>
<ref id="B188">
<label>188</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>HF</given-names></name><name><surname>Mohammad</surname><given-names>SS</given-names></name><name><surname>Reed</surname><given-names>PW</given-names></name><name><surname>Dunn</surname><given-names>PPJ</given-names></name><name><surname>Steele</surname><given-names>RH</given-names></name><name><surname>Dale</surname><given-names>RC</given-names></name><etal></etal></person-group>
<article-title>Anti-N-methyl-d-aspartate receptor encephalitis in Maori and Pacific Island children in New Zealand</article-title>. <source/>Dev Med Child Neurol (<year>2017</year>) <volume>59</volume>(<issue>7</issue>):<page-range>719–24</page-range>. <pub-id pub-id-type="doi">10.1111/dmcn.13420</pub-id>
</mixed-citation>
</ref>
<ref id="B189">
<label>189</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jezequel</surname><given-names>J</given-names></name><name><surname>Rogemond</surname><given-names>V</given-names></name><name><surname>Pollak</surname><given-names>T</given-names></name><name><surname>Lepleux</surname><given-names>M</given-names></name><name><surname>Jacobson</surname><given-names>L</given-names></name><name><surname>Grea</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Cell- and single molecule-based methods to detect anti-N-methyl-D-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE project</article-title>. <source/>Biol Psychiatry (<year>2017</year>) <volume>82</volume>(<issue>10</issue>):<page-range>766–72</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.06.015</pub-id>
</mixed-citation>
</ref>
<ref id="B190">
<label>190</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jezequel</surname><given-names>J</given-names></name><name><surname>Johansson</surname><given-names>EM</given-names></name><name><surname>Dupuis</surname><given-names>JP</given-names></name><name><surname>Rogemond</surname><given-names>V</given-names></name><name><surname>Grea</surname><given-names>H</given-names></name><name><surname>Kellermayer</surname><given-names>B</given-names></name><etal></etal></person-group>
<article-title>Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients</article-title>. <source/>Nat Commun (<year>2017</year>) <volume>8</volume>(<issue>1</issue>):<fpage>1791</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-01700-3</pub-id>
<pub-id pub-id-type="pmid">29176681</pub-id></mixed-citation>
</ref>
<ref id="B191">
<label>191</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hammer</surname><given-names>C</given-names></name><name><surname>Stepniak</surname><given-names>B</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Papiol</surname><given-names>S</given-names></name><name><surname>Tantra</surname><given-names>M</given-names></name><name><surname>Begemann</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity</article-title>. <source/>Mol Psychiatry (<year>2014</year>) <volume>19</volume>(<issue>10</issue>):<page-range>1143–9</page-range>. <pub-id pub-id-type="doi">10.1038/mp.2013.110</pub-id>
</mixed-citation>
</ref>
<ref id="B192">
<label>192</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Castillo-Gomez</surname><given-names>E</given-names></name><name><surname>Kastner</surname><given-names>A</given-names></name><name><surname>Steiner</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Hettling</surname><given-names>B</given-names></name><name><surname>Poggi</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1</article-title>. <source/>Ann Neurol (<year>2016</year>) <volume>79</volume>(<issue>1</issue>):<page-range>144–51</page-range>. <pub-id pub-id-type="doi">10.1002/ana.24545</pub-id>
</mixed-citation>
</ref>
<ref id="B193">
<label>193</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brimberg</surname><given-names>L</given-names></name><name><surname>Mader</surname><given-names>S</given-names></name><name><surname>Jeganathan</surname><given-names>V</given-names></name><name><surname>Berlin</surname><given-names>R</given-names></name><name><surname>Coleman</surname><given-names>TR</given-names></name><name><surname>Gregersen</surname><given-names>PK</given-names></name><etal></etal></person-group>
<article-title>Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice</article-title>. <source/>Mol Psychiatry (<year>2016</year>) <volume>21</volume>(<issue>12</issue>):<page-range>1663–71</page-range>. <pub-id pub-id-type="doi">10.1038/mp.2016.165</pub-id>
</mixed-citation>
</ref>
<ref id="B194">
<label>194</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coutinho</surname><given-names>E</given-names></name><name><surname>Menassa</surname><given-names>DA</given-names></name><name><surname>Jacobson</surname><given-names>L</given-names></name><name><surname>West</surname><given-names>SJ</given-names></name><name><surname>Domingos</surname><given-names>J</given-names></name><name><surname>Moloney</surname><given-names>TC</given-names></name><etal></etal></person-group>
<article-title>Persistent microglial activation and synaptic loss with behavioral abnormalities in mouse offspring exposed to CASPR2-antibodies in utero</article-title>. <source/>Acta Neuropathol (<year>2017</year>) <volume>134</volume>(<issue>4</issue>):<page-range>567–83</page-range>. <pub-id pub-id-type="doi">10.1007/s00401-017-1751-5</pub-id>
</mixed-citation>
</ref>
<ref id="B195">
<label>195</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>KL</given-names></name><name><surname>Pride</surname><given-names>MC</given-names></name><name><surname>Edmiston</surname><given-names>E</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Silverman</surname><given-names>JL</given-names></name><name><surname>Crawley</surname><given-names>JN</given-names></name><etal></etal></person-group>
<article-title>Autism-specific maternal autoantibodies produce behavioral abnormalities in an endogenous antigen-driven mouse model of autism</article-title>. <source/>Mol Psychiatry (<year>2018</year>) in press. <pub-id pub-id-type="doi">10.1038/s41380-018-0126-1</pub-id>
</mixed-citation>
</ref>
<ref id="B196">
<label>196</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coutinho</surname><given-names>E</given-names></name><name><surname>Jacobson</surname><given-names>L</given-names></name><name><surname>Pedersen</surname><given-names>MG</given-names></name><name><surname>Benros</surname><given-names>ME</given-names></name><name><surname>Norgaard-Pedersen</surname><given-names>B</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><etal></etal></person-group>
<article-title>CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism</article-title>. <source/>J Neurol Neurosurg Psychiatry (<year>2017</year>) <volume>88</volume>(<issue>9</issue>):<page-range>718–21</page-range>. <pub-id pub-id-type="doi">10.1136/jnnp-2016-315251</pub-id>
</mixed-citation>
</ref>
<ref id="B197">
<label>197</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jurek</surname><given-names>B</given-names></name><name><surname>Chayka</surname><given-names>M</given-names></name><name><surname>Kreye</surname><given-names>J</given-names></name><name><surname>Lang</surname><given-names>K</given-names></name><name><surname>Kraus</surname><given-names>L</given-names></name><name><surname>Fidzinski</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Human gestational NMDAR autoantibodies impair neonatal murine brain function</article-title>. <source/>Ann Neurol (<year>2019</year>) <volume>86</volume>(<issue>5</issue>):<page-range>656–70</page-range>. <pub-id pub-id-type="doi">10.1002/ana.25552</pub-id>
</mixed-citation>
</ref>
<ref id="B198">
<label>198</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blanpied</surname><given-names>TA</given-names></name><name><surname>Clarke</surname><given-names>RJ</given-names></name><name><surname>Johnson</surname><given-names>JW</given-names></name></person-group>
<article-title>Amantadine inhibits NMDA receptors by accelerating channel closure during channel block</article-title>. <source/>J Neurosci (<year>2005</year>) <volume>25</volume>(<issue>13</issue>):<page-range>3312–22</page-range>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4262-04.2005</pub-id>
</mixed-citation>
</ref>
<ref id="B199">
<label>199</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kohm</surname><given-names>AP</given-names></name><name><surname>Fuller</surname><given-names>KG</given-names></name><name><surname>Miller</surname><given-names>SD</given-names></name></person-group>
<article-title>Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology</article-title>. <source/>Trends In Microbiol (<year>2003</year>) <volume>11</volume>(<issue>3</issue>):<page-range>101–5</page-range>. <pub-id pub-id-type="doi">10.1016/S0966-842X(03)00006-4</pub-id>
</mixed-citation>
</ref>
<ref id="B200">
<label>200</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ercolini</surname><given-names>AM</given-names></name><name><surname>Miller</surname><given-names>SD</given-names></name></person-group>
<article-title>The role of infections in autoimmune disease</article-title>. <source/>Clin Exp Immunol (<year>2009</year>) <volume>155</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2008.03834.x</pub-id>
<pub-id pub-id-type="pmid">19076824</pub-id></mixed-citation>
</ref>
<ref id="B201">
<label>201</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Munz</surname><given-names>C</given-names></name><name><surname>Lunemann</surname><given-names>JD</given-names></name><name><surname>Getts</surname><given-names>MT</given-names></name><name><surname>Miller</surname><given-names>SD</given-names></name></person-group>
<article-title>Antiviral immune responses: triggers of or triggered by autoimmunity?</article-title>
<source/>Nat Rev Immunol (<year>2009</year>) <volume>9</volume>(<issue>4</issue>):<page-range>246–58</page-range>. <pub-id pub-id-type="doi">10.1038/nri2527</pub-id>
</mixed-citation>
</ref>
<ref id="B202">
<label>202</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toplak</surname><given-names>N</given-names></name><name><surname>Avcin</surname><given-names>T</given-names></name></person-group>
<article-title>Influenza and autoimmunity</article-title>. <source/>Ann N Y Acad Sci (<year>2009</year>) <volume>1173</volume>:<page-range>619–26</page-range>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.04759.x</pub-id>
</mixed-citation>
</ref>
<ref id="B203">
<label>203</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toplak</surname><given-names>N</given-names></name><name><surname>Kveder</surname><given-names>T</given-names></name><name><surname>Trampus-Bakija</surname><given-names>A</given-names></name><name><surname>Subelj</surname><given-names>V</given-names></name><name><surname>Cucnik</surname><given-names>S</given-names></name><name><surname>Avcin</surname><given-names>T</given-names></name></person-group>
<article-title>Autoimmune response following annual influenza vaccination in 92 apparently healthy adults</article-title>. <source/>Autoimmun Rev (<year>2008</year>) <volume>8</volume>(<issue>2</issue>):<page-range>134–8</page-range>. <pub-id pub-id-type="doi">10.1016/j.autrev.2008.07.008</pub-id>
</mixed-citation>
</ref>
<ref id="B204">
<label>204</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laing</surname><given-names>P</given-names></name><name><surname>Knight</surname><given-names>JG</given-names></name><name><surname>Hill</surname><given-names>JM</given-names></name><name><surname>Harris</surname><given-names>AG</given-names></name><name><surname>Oxford</surname><given-names>JS</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name><etal></etal></person-group>
<article-title>Influenza viruses induce autoantibodies to a brain-specific 37-kDa protein in rabbit</article-title>. <source/>Proc Natl Acad Sci U S A (<year>1989</year>) <volume>86</volume>(<issue>6</issue>):<fpage>1998</fpage>–<lpage>2002</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.86.6.1998</pub-id>
<pub-id pub-id-type="pmid">2467294</pub-id></mixed-citation>
</ref>
<ref id="B205">
<label>205</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vellozzi</surname><given-names>C</given-names></name><name><surname>Iqbal</surname><given-names>S</given-names></name><name><surname>Broder</surname><given-names>K</given-names></name></person-group>
<article-title>Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence</article-title>. <source/>Clin Infect Dis (<year>2014</year>) <volume>58</volume>(<issue>8</issue>):<page-range>1149–55</page-range>. <pub-id pub-id-type="doi">10.1093/cid/ciu005</pub-id>
</mixed-citation>
</ref>
<ref id="B206">
<label>206</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kornum</surname><given-names>BR</given-names></name><name><surname>Faraco</surname><given-names>J</given-names></name><name><surname>Mignot</surname><given-names>E</given-names></name></person-group>
<article-title>Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain</article-title>. <source/>Curr Opin In Neurobiol (<year>2011</year>) <volume>21</volume>(<issue>6</issue>):<fpage>897</fpage>–<lpage>903</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2011.09.003</pub-id>
</mixed-citation>
</ref>
<ref id="B207">
<label>207</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Mahlios</surname><given-names>J</given-names></name><name><surname>Mignot</surname><given-names>E</given-names></name></person-group>
<article-title>Genetic association, seasonal infections and autoimmune basis of narcolepsy</article-title>. <source/>J Autoimmun (<year>2013</year>) <volume>43</volume>:<fpage>26</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2013.02.003</pub-id>
<pub-id pub-id-type="pmid">23497937</pub-id></mixed-citation>
</ref>
<ref id="B208">
<label>208</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Partinen</surname><given-names>M</given-names></name><name><surname>Kornum</surname><given-names>BR</given-names></name><name><surname>Plazzi</surname><given-names>G</given-names></name><name><surname>Jennum</surname><given-names>P</given-names></name><name><surname>Julkunen</surname><given-names>I</given-names></name><name><surname>Vaarala</surname><given-names>O</given-names></name></person-group>
<article-title>Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination</article-title>. <source/>Lancet Neurol (<year>2014</year>) <volume>13</volume>(<issue>6</issue>):<page-range>600–13</page-range>. <pub-id pub-id-type="doi">10.1016/S1474-4422(14)70075-4</pub-id>
</mixed-citation>
</ref>
<ref id="B209">
<label>209</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>E</given-names></name><name><surname>Andrews</surname><given-names>N</given-names></name><name><surname>Stellitano</surname><given-names>L</given-names></name><name><surname>Stowe</surname><given-names>J</given-names></name><name><surname>Winstone</surname><given-names>AM</given-names></name><name><surname>Shneerson</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis</article-title>. <source/>BMJ (<year>2013</year>) <volume>346</volume>:<fpage>f794</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.f794</pub-id>
<pub-id pub-id-type="pmid">23444425</pub-id></mixed-citation>
</ref>
<ref id="B210">
<label>210</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Partinen</surname><given-names>M</given-names></name><name><surname>Saarenpaa-Heikkila</surname><given-names>O</given-names></name><name><surname>Ilveskoski</surname><given-names>I</given-names></name><name><surname>Hublin</surname><given-names>C</given-names></name><name><surname>Linna</surname><given-names>M</given-names></name><name><surname>Olsen</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland</article-title>. <source/>PloS One (<year>2012</year>) <volume>7</volume>(<issue>3</issue>):<fpage>e33723</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033723</pub-id>
<pub-id pub-id-type="pmid">22470463</pub-id></mixed-citation>
</ref>
<ref id="B211">
<label>211</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>SS</given-names></name><name><surname>Volkmuth</surname><given-names>W</given-names></name><name><surname>Duca</surname><given-names>J</given-names></name><name><surname>Corti</surname><given-names>L</given-names></name><name><surname>Pallaoro</surname><given-names>M</given-names></name><name><surname>Pezzicoli</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2</article-title>. <source/>Sci Transl Med (<year>2015</year>) <volume>7</volume>(<issue>294</issue>):<fpage>294ra105</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aab2354</pub-id>
</mixed-citation>
</ref>
<ref id="B212">
<label>212</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vassalli</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Tafti</surname><given-names>M</given-names></name></person-group>
<article-title>Comment on “Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2”</article-title>. <source/>Sci Transl Med (<year>2015</year>) <volume>7</volume>(<issue>314</issue>):<fpage>314le2</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aad2353</pub-id>
</mixed-citation>
</ref>
<ref id="B213">
<label>213</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Jacob</surname><given-names>L</given-names></name><name><surname>Bonvalet</surname><given-names>M</given-names></name><name><surname>Ambati</surname><given-names>A</given-names></name><name><surname>Plazzi</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases</article-title>. <source/>PloS One (<year>2017</year>) <volume>12</volume>(<issue>12</issue>):<fpage>e0187305</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0187305</pub-id>
<pub-id pub-id-type="pmid">29220370</pub-id></mixed-citation>
</ref>
<ref id="B214">
<label>214</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Ambati</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Bonvalet</surname><given-names>M</given-names></name><name><surname>Partinen</surname><given-names>M</given-names></name><name><surname>Ji</surname><given-names>X</given-names></name><etal></etal></person-group>
<article-title>Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2018</year>) <volume>115</volume>(<issue>52</issue>):<page-range>E12323–32</page-range>. <pub-id pub-id-type="doi">10.1073/pnas.1818150116</pub-id>
</mixed-citation>
</ref>
<ref id="B215">
<label>215</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanduc</surname><given-names>D</given-names></name></person-group>
<article-title>Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes</article-title>. <source/>Biologics : Targets Ther (<year>2010</year>) <volume>4</volume>:<page-range>245–61</page-range>. <pub-id pub-id-type="doi">10.2147/BTT.S12097</pub-id>
</mixed-citation>
</ref>
<ref id="B216">
<label>216</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lucchese</surname><given-names>G</given-names></name><name><surname>Capone</surname><given-names>G</given-names></name><name><surname>Kanduc</surname><given-names>D</given-names></name></person-group>
<article-title>Peptide sharing between influenza a H1N1 hemagglutinin and human axon guidance Proteins</article-title>. <source/>Schizophr Bull (<year>2014</year>) <volume>40</volume>(<issue>2</issue>):<page-range>362–75</page-range>. <pub-id pub-id-type="doi">10.1093/schbul/sbs197</pub-id>
</mixed-citation>
</ref>
<ref id="B217">
<label>217</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lucchese</surname><given-names>G</given-names></name></person-group>
<article-title>Understanding neuropsychiatric diseases, analyzing the peptide sharing between infectious agents and the language-associated NMDA 2A protein</article-title>. <source/>Front In Psychiatry (<year>2016</year>) <volume>7</volume>:<elocation-id>60</elocation-id>. <pub-id pub-id-type="doi">10.3389/fpsyt.2016.00060</pub-id>
</mixed-citation>
</ref>
<ref id="B218">
<label>218</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kepinska</surname><given-names>A</given-names></name><name><surname>Pollak</surname><given-names>T</given-names></name><name><surname>Iyegbe</surname><given-names>C</given-names></name><name><surname>Murray</surname><given-names>R</given-names></name></person-group>
<article-title>T189. Peptide sharing between schizophrenia-related proteins and the influenza a virus may offer a window into the immune aetiology of psychotic disorders</article-title>. <source/>Schizophr Bull (<year>2018</year>) <volume>44</volume>(<issue>suppl_1</issue>):<page-range>S189–9</page-range>. <pub-id pub-id-type="doi">10.1093/schbul/sby016.465</pub-id>
</mixed-citation>
</ref>
<ref id="B219">
<label>219</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harrison</surname><given-names>NA</given-names></name><name><surname>Cercignani</surname><given-names>M</given-names></name><name><surname>Voon</surname><given-names>V</given-names></name><name><surname>Critchley</surname><given-names>HD</given-names></name></person-group>
<article-title>Effects of inflammation on hippocampus and substantia nigra responses to novelty in healthy human participants</article-title>. <source/>Neuropsychopharmacology (<year>2015</year>) <volume>40</volume>(<issue>4</issue>):<page-range>831–8</page-range>. <pub-id pub-id-type="doi">10.1038/npp.2014.222</pub-id>
</mixed-citation>
</ref>
<ref id="B220">
<label>220</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harrison</surname><given-names>NA</given-names></name><name><surname>Brydon</surname><given-names>L</given-names></name><name><surname>Walker</surname><given-names>C</given-names></name><name><surname>Gray</surname><given-names>MA</given-names></name><name><surname>Steptoe</surname><given-names>A</given-names></name><name><surname>Critchley</surname><given-names>HD</given-names></name></person-group>
<article-title>Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity</article-title>. <source/>Biol Psychiatry (<year>2009</year>) <volume>66</volume>(<issue>5</issue>):<page-range>407–14</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.03.015</pub-id>
</mixed-citation>
</ref>
<ref id="B221">
<label>221</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harrison</surname><given-names>NA</given-names></name><name><surname>Brydon</surname><given-names>L</given-names></name><name><surname>Walker</surname><given-names>C</given-names></name><name><surname>Gray</surname><given-names>MA</given-names></name><name><surname>Steptoe</surname><given-names>A</given-names></name><name><surname>Dolan</surname><given-names>RJ</given-names></name><etal></etal></person-group>
<article-title>Neural origins of human sickness in interoceptive responses to inflammation</article-title>. <source/>Biol Psychiatry (<year>2009</year>) <volume>66</volume>(<issue>5</issue>):<page-range>415–22</page-range>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.03.007</pub-id>
</mixed-citation>
</ref>
<ref id="B222">
<label>222</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marques</surname><given-names>TR</given-names></name><name><surname>Ashok</surname><given-names>AH</given-names></name><name><surname>Pillinger</surname><given-names>T</given-names></name><name><surname>Veronese</surname><given-names>M</given-names></name><name><surname>Turkheimer</surname><given-names>FE</given-names></name><name><surname>Dazzan</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies</article-title>. <source/>Psychol Med (<year>2019</year>) <volume>49</volume>(<issue>13</issue>), <page-range>2186–96</page-range>. <pub-id pub-id-type="doi">10.1017/S0033291718003057</pub-id>
</mixed-citation>
</ref>
<ref id="B223">
<label>223</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holmes</surname><given-names>SE</given-names></name><name><surname>Hinz</surname><given-names>R</given-names></name><name><surname>Drake</surname><given-names>RJ</given-names></name><name><surname>Gregory</surname><given-names>CJ</given-names></name><name><surname>Conen</surname><given-names>S</given-names></name><name><surname>Matthews</surname><given-names>JC</given-names></name><etal></etal></person-group>
<article-title>In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study</article-title>. <source/>Mol Psychiatry (<year>2016</year>) <volume>21</volume>(<issue>12</issue>):<page-range>1672–9</page-range>. <pub-id pub-id-type="doi">10.1038/mp.2016.180</pub-id>
</mixed-citation>
</ref>
<ref id="B224">
<label>224</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quadrato</surname><given-names>G</given-names></name><name><surname>Brown</surname><given-names>J</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group>
<article-title>The promises and challenges of human brain organoids as models of neuropsychiatric disease</article-title>. <source/>Nat Med (<year>2016</year>) <volume>22</volume>(<issue>11</issue>):<page-range>1220–8</page-range>. <pub-id pub-id-type="doi">10.1038/nm.4214</pub-id>
</mixed-citation>
</ref>
<ref id="B225">
<label>225</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cono</surname><given-names>J</given-names></name><name><surname>Cragan</surname><given-names>JD</given-names></name><name><surname>Jamieson</surname><given-names>DJ</given-names></name><name><surname>Rasmussen</surname><given-names>SA</given-names></name></person-group>
<article-title>Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies</article-title>. <source/>Emerg Infect Dis (<year>2006</year>) <volume>12</volume>(<issue>11</issue>):<page-range>1631–7</page-range>. <pub-id pub-id-type="doi">10.3201/eid1211.060618</pub-id>
</mixed-citation>
</ref>
<ref id="B226">
<label>226</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yudin</surname><given-names>MH</given-names></name></person-group>
<article-title>Optimizing knowledge of antiviral medications for prophylaxis and treatment of influenza during pregnancy</article-title>. <source/>Expert Rev Respir Med (<year>2011</year>) <volume>5</volume>(<issue>4</issue>):<fpage>495</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1586/ers.11.37</pub-id>
<pub-id pub-id-type="pmid">21859269</pub-id></mixed-citation>
</ref>
<ref id="B227">
<label>227</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bednarczyk</surname><given-names>RA</given-names></name><name><surname>Adjaye-Gbewonyo</surname><given-names>D</given-names></name><name><surname>Omer</surname><given-names>SB</given-names></name></person-group>
<article-title>Safety of influenza immunization during pregnancy for the fetus and the neonate</article-title>. <source/>Am J Obstet Gynecol (<year>2012</year>) <volume>207</volume>(<issue>3 Suppl</issue>):<page-range>S38–46</page-range>. <pub-id pub-id-type="doi">10.1016/j.ajog.2012.07.002</pub-id>
</mixed-citation>
</ref>
<ref id="B228">
<label>228</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Haddad</surname><given-names>BJS</given-names></name><name><surname>Oler</surname><given-names>E</given-names></name><name><surname>Armistead</surname><given-names>B</given-names></name><name><surname>Elsayed</surname><given-names>NA</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Bernier</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>The fetal origins of mental illness</article-title>. <source/>Am J Obstet Gynecol (<year>2019</year>) <volume>221</volume>(<issue>6</issue>): <page-range>549–62</page-range>. <pub-id pub-id-type="doi">10.1016/j.ajog.2019.06.013</pub-id>
</mixed-citation>
</ref>
<ref id="B229">
<label>229</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hviid</surname><given-names>A</given-names></name><name><surname>Svanstrom</surname><given-names>H</given-names></name><name><surname>Molgaard-Nielsen</surname><given-names>D</given-names></name><name><surname>Lambach</surname><given-names>P</given-names></name></person-group>
<article-title>Association between pandemic influenza A(H1N1) vaccination in pregnancy and early childhood morbidity in offspring</article-title>. <source/>JAMA Pediatr (<year>2017</year>) <volume>171</volume>(<issue>3</issue>):<page-range>239–48</page-range>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2016.4023</pub-id>
</mixed-citation>
</ref>
<ref id="B230">
<label>230</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>F</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name></person-group>
<article-title>Influenza A(H1N1) vaccination during early pregnancy transiently promotes hippocampal neurogenesis and working memory. involvement of Th1/Th2 balance</article-title>. <source/>Brain Res (<year>2014</year>) <volume>1592</volume>:<fpage>34</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2014.09.076</pub-id>
<pub-id pub-id-type="pmid">25307140</pub-id></mixed-citation>
</ref>
<ref id="B231">
<label>231</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>F</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name></person-group>
<article-title>Influenza vaccination during early pregnancy contributes to neurogenesis and behavioral function in offspring</article-title>. <source/>Brain Behav Immun (<year>2014</year>) <volume>42</volume>:<page-range>212–21</page-range>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.06.202</pub-id>
</mixed-citation>
</ref>
<ref id="B232">
<label>232</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zerbo</surname><given-names>O</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>C</given-names></name><name><surname>Fireman</surname><given-names>BH</given-names></name><name><surname>Klein</surname><given-names>NP</given-names></name><name><surname>Croen</surname><given-names>LA</given-names></name></person-group>
<article-title>Association between influenza infection and vaccination during pregnancy and risk of autism spectrum disorder</article-title>. <source/>JAMA Pediatr (<year>2017</year>) <volume>171</volume>(<issue>1</issue>):<fpage>e163609</fpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2016.3609</pub-id>
<pub-id pub-id-type="pmid">27893896</pub-id></mixed-citation>
</ref>
<ref id="B233">
<label>233</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sandy</surname><given-names>K</given-names></name><name><surname>Gandham</surname><given-names>S</given-names></name><name><surname>Nanan</surname><given-names>R</given-names></name></person-group>
<article-title>Influenza a infections in infants of vaccinated and unvaccinated mothers</article-title>. <source/>JAMA Pediatr (<year>2017</year>) <volume>171</volume>(<issue>10</issue>):<page-range>1014–5</page-range>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2017.2391</pub-id>
</mixed-citation>
</ref>
<ref id="B234">
<label>234</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hviid</surname><given-names>A</given-names></name><name><surname>Svanstrom</surname><given-names>H</given-names></name></person-group>
<article-title>Influenza a infections in infants of vaccinated and unvaccinated mothers-reply</article-title>. <source/>JAMA Pediatr (<year>2017</year>) <volume>171</volume>(<issue>10</issue>):<fpage>1015</fpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2017.2394</pub-id>
</mixed-citation>
</ref>
<ref id="B235">
<label>235</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>U</given-names></name></person-group>
<article-title>Neurodevelopmental resilience and susceptibility to maternal immune activation</article-title>. <source/>Trends Neurosci (<year>2019</year>) <volume>42</volume>(<issue>11</issue>):<fpage>793</fpage>–<lpage>806</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2019.08.001</pub-id>
<pub-id pub-id-type="pmid">31493924</pub-id></mixed-citation>
</ref>
<ref id="B236">
<label>236</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Leung</surname><given-names>YO</given-names></name><name><surname>Zhou</surname><given-names>I</given-names></name><name><surname>Ho</surname><given-names>LC</given-names></name><name><surname>Kong</surname><given-names>W</given-names></name><name><surname>Basil</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Dietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model</article-title>. <source/>Transl Psychiatry (<year>2015</year>) <volume>5</volume>:<fpage>e641</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2015.126</pub-id>
<pub-id pub-id-type="pmid">26393487</pub-id></mixed-citation>
</ref>
<ref id="B237">
<label>237</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basil</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Gui</surname><given-names>H</given-names></name><name><surname>Hui</surname><given-names>TCK</given-names></name><name><surname>Ling</surname><given-names>VHM</given-names></name><name><surname>Wong</surname><given-names>CCY</given-names></name><etal></etal></person-group>
<article-title>Prenatal immune activation alters the adult neural epigenome but can be partly stabilised by a n-3 polyunsaturated fatty acid diet</article-title>. <source/>Transl Psychiatry (<year>2018</year>) <volume>8</volume>(<issue>1</issue>):<fpage>125</fpage>. <pub-id pub-id-type="doi">10.1038/s41398-018-0167-x</pub-id>
<pub-id pub-id-type="pmid">29967385</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>